Publications

Publications published since 2010 from OUS - Department of Oncology

2469 publications found (only first 1000 shown)

Publications 2024

  1. Alm-Kruse K, Gjerset GM, Tjelmeland IBM, Isern CB, Kramer-Johansen J, Garratt AM (2024)
    How do survivors after out-of-hospital cardiac arrest perceive their health compared to the norm population? A nationwide registry study from Norway
    Resusc Plus, 17, 100549
    DOI 10.1016/j.resplu.2023.100549, PubMed 38292469
  2. Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA (2024)
    Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
    J Immunother Cancer, 12 (1)
    DOI 10.1136/jitc-2023-007990, PubMed 38242720
  3. Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S (2024)
    Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
    Med (in press)
    DOI 10.1016/j.medj.2024.03.007, PubMed 38579729
  4. Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2024)
    Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
    Gynecol Oncol, 183, 7-8 (in press)
    DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693
  5. Bjerring AW, Smeland KH, Stokke T, Haugaa KH, Holte E, Rösner A, Kiserud CE, Edvardsen T, Sarvari SI (2024)
    Long-term cardiac effects of modern treatment for Hodgkin's lymphoma
    Cardiooncology, 10 (1), 19
    DOI 10.1186/s40959-024-00222-4, PubMed 38576044
  6. Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
    The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
    J Neurooncol (in press)
    DOI 10.1007/s11060-024-04709-z, PubMed 38762830
  7. Brativnyk A, Ankill J, Helland Å, Fleischer T (2024)
    Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma
    Int J Cancer, 155 (2), 282-297
    DOI 10.1002/ijc.34915, PubMed 38489486
  8. Brenne AT, Løhre ET, Knudsen AK, Lund JÅ, Thronæs M, Driller B, Brunelli C, Kaasa S (2024)
    Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial
    Oncol Ther (in press)
    DOI 10.1007/s40487-024-00278-3, PubMed 38744750
  9. Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE, ‘Cachexia Endpoint Series Working Group’ (2024)
    Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
    J Cachexia Sarcopenia Muscle (in press)
    DOI 10.1002/jcsm.13478, PubMed 38738581
  10. Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M et al. (2024)
    Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
    Eur J Cancer, 202, 114042
    DOI 10.1016/j.ejca.2024.114042, PubMed 38564927
  11. Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
    Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
    J Immunother Cancer, 12 (4)
    DOI 10.1136/jitc-2023-008179, PubMed 38604812
  12. Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
    CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
    Cell Rep Med, 101572 (in press)
    DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
  13. Chauhan SK, Dunn C, Andresen NK, Røssevold AH, Skorstad G, Sike A, Gilje B, Raj SX, Huse K, Naume B, Kyte JA (2024)
    Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation
    NPJ Breast Cancer, 10 (1), 30
    DOI 10.1038/s41523-024-00638-2, PubMed 38653982
  14. Chen N, McGrath CB, Ericsson CI, Vaselkiv JB, Rencsok EM, Stopsack KH, Guard HE, Autio KA, Rathkopf DE, Enting D, Bitting RL, Mateo J, Githiaka CW, Chi KN, Cheng HH, Davis ID, Anderson SG, Badal SAM, Bjartell A, Russnes KM, Heath EI, Pomerantz MM, Henegan JC, Hyslop T, Esteban E et al. (2024)
    Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer
    Cancer Epidemiol Biomarkers Prev, 33 (3), 419-425
    DOI 10.1158/1055-9965.EPI-23-1207, PubMed 38189661
  15. Chen ZJ, Li XA, Brenner DJ, Hellebust TP, Hoskin P, Joiner MC, Kirisits C, Nath R, Rivard MJ, Thomadsen BR, Zaider M (2024)
    AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy
    Med Phys (in press)
    DOI 10.1002/mp.17062, PubMed 38721942
  16. Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M (2024)
    Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma
    NPJ Precis Oncol, 8 (1), 26
    DOI 10.1038/s41698-024-00506-z, PubMed 38302615
  17. Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
    Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
    Radiother Oncol, 195, 110273
    DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
  18. Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB (2024)
    Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
    J Natl Cancer Inst, 116 (3), 455-467
    DOI 10.1093/jnci/djad236, PubMed 37966940
  19. Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U et al. (2024)
    Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
    Lancet (in press)
    DOI 10.1016/S0140-6736(24)00184-3, PubMed 38705160
  20. Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2024)
    Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
    Blood, 143 (17), 1713-1725
    DOI 10.1182/blood.2023021567, PubMed 38194692
  21. Festvåg LE, Sverre BL, Paulsen Ø, Eilertsen G (2024)
    Advance care planning with older Norwegian adults in their homes: a narrative ethnographic study
    BMC Palliat Care, 23 (1), 44
    DOI 10.1186/s12904-024-01378-7, PubMed 38369465
  22. Fleischer T, Haugen MH, Ankill J, Silwal-Pandit L, Børresen-Dale AL, Hedenfalk I, Hatschek T, Tost J, Engebraaten O, Kristensen VN (2024)
    An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
    Mol Oncol (in press)
    DOI 10.1002/1878-0261.13656, PubMed 38671580
  23. Fosså SD, Holck Storås A, Aas K, Børge Johannesen T, Maria Gjelsvik Y, Myklebust TÅ (2024)
    Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer
    Eur Urol Open Sci, 63, 62-70
    DOI 10.1016/j.euros.2024.03.005, PubMed 38558766
  24. Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
    Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
    BJU Int, 133 (6), 717-724
    DOI 10.1111/bju.16289, PubMed 38293778
  25. Gomes LA, Rodrigues AM, van der Windt D, Pires D, Afreixo V, Canhão H, Cruz EB (2024)
    Minimal Intervention of Patient Education for Low Back Pain: A Systematic Review With Meta-analysis
    J Orthop Sports Phys Ther, 54 (2), 1-13
    DOI 10.2519/jospt.2023.11865, PubMed 37970797
  26. Grivas P, Garralda E, Meric-Bernstam F, Mellinghoff IK, Goyal L, Harding JJ, Dees EC, Bahleda R, Azad NS, Karippot A, Kurzrock R, Tabernero J, Kononen J, Ng MCH, Mehta R, Uboha NV, Bigot F, Boni V, Bowyer SE, Breder V, Cervantes A, Chan N, Cleary JM, Dhawan M, Eefsen RL et al. (2024)
    Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial
    Clin Cancer Res (in press)
    DOI 10.1158/1078-0432.CCR-24-0012, PubMed 38771739
  27. Guldvik IJ, Ramberg H, Kristensen G, Røder A, Mills IG, Lilleby W, Taskén KA (2024)
    Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
    World J Urol, 42 (1), 95
    DOI 10.1007/s00345-024-04787-8, PubMed 38386171
  28. Gullhaug A, Haakensen VD, De Ruysscher D, Simone CB, Hotca-Cho AE, Chhabra AM, Hellebust TP, Paulsen EE, Dimopoulos MP, Johansen S (2024)
    Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes
    J Med Imaging Radiat Sci (in press)
    DOI 10.1016/j.jmir.2024.02.004, PubMed 38429174
  29. Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144 (1)
    DOI 10.4045/tidsskr.23.0740, PubMed 38258713
  30. Heramb-Aamot J, Mala T, Fauske L (2024)
    Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
    Anticancer Res, 44 (2), 743-750
    DOI 10.21873/anticanres.16865, PubMed 38307550
  31. Hjermstad MJ, Jakobsen G, Arends J, Balstad T, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM et al. (2024)
    Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
    J Cachexia Sarcopenia Muscle (in press)
    DOI 10.1002/jcsm.13453, PubMed 38553255
  32. Hjermstad MJ, Pirnat A, Aass N, Andersen S, Astrup GL, Dajani O, Garresori H, Guldhav KV, Hamre H, Haukland EC, Jordal F, Lundeby T, Løhre ET, Mjåland S, Paulsen Ø, Semb KA, Staff ES, Wester T, Kaasa S (2024)
    PALLiative care in ONcology (PALLiON): A cluster-randomised trial investigating the effect of palliative care on the use of anticancer treatment at the end of life
    Palliat Med, 38 (2), 229-239
    DOI 10.1177/02692163231222391, PubMed 38193250
  33. Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø (2024)
    Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
    Acta Oncol, 63, 288-293
    DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
  34. Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
    Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
    Radiother Oncol, 195, 110231
    DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
  35. Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å (2024)
    UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
    Eur J Cancer, 202, 113973
    DOI 10.1016/j.ejca.2024.113973, PubMed 38447379
  36. Jerkeman M, Kolstad A, Hutchings M, Pasanen A, Meriranta L, Niemann CU, Kragh Jørgensen RR, El-Galaly TC, Riise J, Leppä S, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I (2024)
    MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial
    Blood Adv, 8 (2), 407-415
    DOI 10.1182/bloodadvances.2023011920, PubMed 38113470
  37. Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA (2024)
    Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers
    Int J Mol Sci, 25 (1)
    DOI 10.3390/ijms25010586, PubMed 38203757
  38. Karlsson AT, Hjermstad MJ, Aass N, Skovlund E, Kaasa S, Yri OE (2024)
    Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients
    Cancers (Basel), 16 (8)
    DOI 10.3390/cancers16081486, PubMed 38672568
  39. Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Samsøe E, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Overgaard J, Eriksen JG (2024)
    High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study
    Clin Transl Radiat Oncol, 46, 100772
    DOI 10.1016/j.ctro.2024.100772, PubMed 38596816
  40. Kristensen MH, Sørensen MK, Tramm T, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Lilja-Fischer JK, Holm AIS, Samsøe E, Hansen CR, Zukauskaite R, Overgaard J, Eriksen JG (2024)
    Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
    Radiother Oncol, 193, 110149
    DOI 10.1016/j.radonc.2024.110149, PubMed 38341096
  41. Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D et al. (2024)
    Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
    Lancet Gastroenterol Hepatol, 9 (3), 205-217
    DOI 10.1016/S2468-1253(23)00405-3, PubMed 38237621
  42. Labori KJ, Bratlie SO, Dueland S, Lassen K (2024)
    NORPACT-1: implications for future trials - Authors' reply
    Lancet Gastroenterol Hepatol, 9 (5), 408-409
    DOI 10.1016/S2468-1253(24)00079-7, PubMed 38604194
  43. Lia K, Jørgensen RRK, L Wold B, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Fosså A (2024)
    Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study
    Haematologica, 109 (5), 1403-1412
    DOI 10.3324/haematol.2023.283721, PubMed 37881879
  44. Lilleby W, Kishan A, Geinitz H (2024)
    Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer
    World J Urol, 42 (1), 41
    DOI 10.1007/s00345-023-04714-3, PubMed 38244053
  45. Lillekroken D, Bye A, Halvorsrud L, Terragni L, Debesay J (2024)
    Food for Soul-Older Immigrants' Food Habits and Meal Preferences After Immigration: A Systematic Literature Review
    J Immigr Minor Health (in press)
    DOI 10.1007/s10903-023-01571-5, PubMed 38165601
  46. Lund JÅ, Lydersen S, Aksnessæther B, Solberg A, Wanderås A, Lervåg C, Kaasa S, Tøndel H (2024)
    Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial)
    Radiother Oncol, 196, 110309 (in press)
    DOI 10.1016/j.radonc.2024.110309, PubMed 38670265
  47. Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessæther B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K, Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get‐Randomized (GRand) Initiative (2024)
    Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
    BJU Int, 133 (6), 680-689
    DOI 10.1111/bju.16314, PubMed 38469686
  48. Machak GN, Bruland ØS, Romanova TN, Kovalev AV (2024)
    Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
    J Bone Oncol, 45, 100596
    DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
  49. Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM (2024)
    Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
    Mol Ther (in press)
    DOI 10.1016/j.ymthe.2024.04.009, PubMed 38582964
  50. Mahon P, Chatzitheofilou I, Dekker A, Fernández X, Hall G, Helland A, Traverso A, Van Marcke C, Vehreschild J, Ciliberto G, Tonon G (2024)
    A federated learning system for precision oncology in Europe: DigiONE
    Nat Med, 30 (2), 334-337
    DOI 10.1038/s41591-023-02715-8, PubMed 38195748
  51. Miceli R, Eriksson H, Lo Russo G, Alfieri S, Moksnes Bjaanæs M, Pietrantonio F, De Cecco L, Prelaj A, Proto C, Franzén J, McDonnell D, Berenguer Pina JJ, Beninato T, Mazzeo L, Giannatempo P, Verzoni E, Crown J, Helland Å, Eustace A (2024)
    Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study
    Acta Oncol, 63, 213-219
    DOI 10.2340/1651-226X.2024.24179, PubMed 38647024
  52. Nilssen Y, Brustugun OT, Fjellbirkeland L, Grønberg BH, Haram PM, Helbekkmo N, Helland Å, Wahl SGF, Aanerud M, Solberg S (2024)
    Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends
    Clin Lung Cancer (in press)
    DOI 10.1016/j.cllc.2024.04.002, PubMed 38692990
  53. Nilssen Y, Brustugun OT, Fjellbirkeland L, Helland Å, Møller B, Wahl SGF, Solberg S (2024)
    Distribution and characteristics of malignant tumours by lung lobe
    BMC Pulm Med, 24 (1), 106
    DOI 10.1186/s12890-024-02918-w, PubMed 38439038
  54. Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A (2024)
    The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study
    Clin Nutr ESPEN, 61, 101-107
    DOI 10.1016/j.clnesp.2024.03.006, PubMed 38777421
  55. Os SS, Skipar K, Skovlund E, Hompland I, Hellebust TP, Guren MG, Lindemann K, Nakken ES (2024)
    Survival prediction in patients with gynecological cancer irradiated for brain metastases
    Acta Oncol, 63, 206-212
    DOI 10.2340/1651-226X.2023.34899, PubMed 38647023
  56. Papadakis V, Astigarraga I, van den Bos C, Donadieu J, Henter JI, Jacobs S, Lehrnbecher T, Munthe-Kaas MC, Naeije L, Nanduri V, Nguyen T, Nysom K, Pears J, Raciborska A, Sieni E, Svojgr K, Tzotzola V, Minkov M, European Consortium for Histiocytosis (ECHO) (2024)
    The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis
    Pediatr Blood Cancer, 71 (3), e30850
    DOI 10.1002/pbc.30850, PubMed 38185727
  57. Puco K, Fagereng GL, Brabrand S, Niehusmann P, Støre Blix E, Samdal Steinskog ES, Haug Å, Fredvik Torkildsen C, Oppedal IA, Meltzer S, Flobak Å, Johansson KAM, Bjørge L, Hjortland GO, Dalhaug A, Lund JÅ, Gilje B, Grønlie Cameron M, Hovland R, Falk RS, Smeland S, Giercksky Russnes HE, Taskén K, Helland Å, InPreD Consortium et al. (2024)
    IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
    Acta Oncol, 63, 379-384
    DOI 10.2340/1651-226X.2024.28322, PubMed 38779911
  58. Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli UM, Erlanson M, Fluge Ø, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M (2024)
    Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
    Haematologica (in press)
    DOI 10.3324/haematol.2024.285207, PubMed 38546689
  59. Rask Kragh Jørgensen R, Bergström F, Eloranta S, Tang Severinsen M, Bjøro Smeland K, Fosså A, Haaber Christensen J, Hutchings M, Bo Dahl-Sørensen R, Kamper P, Glimelius I, E Smedby K, K Parsons S, Mae Rodday A, J Maurer M, M Evens A, C El-Galaly T, Hjort Jakobsen L (2024)
    Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
    JCO Clin Cancer Inform, 8, e2300255
    DOI 10.1200/CCI.23.00255, PubMed 38608215
  60. Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S (2024)
    First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial
    Br J Cancer (in press)
    DOI 10.1038/s41416-024-02696-6, PubMed 38664577
  61. Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R et al. (2024)
    The 1+Million Genomes Minimal Dataset for Cancer
    Nat Genet, 56 (5), 733-736
    DOI 10.1038/s41588-024-01721-x, PubMed 38702538
  62. Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, Heard E, Heitor M, Chandy M, Chen CJ, Costa A, De Lorenzo F, De Robertis EM, Dubee FC, Ernberg I, Gabriel M, Helland Å, Henrique R, Jönsson B, Kallioniemi O, Korbel J, Krause M, Lowy DR, Michielin O, Nagy P et al. (2024)
    Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023
    Mol Oncol, 18 (2), 245-279
    DOI 10.1002/1878-0261.13575, PubMed 38135904
  63. Schlichting E (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144 (5)
    DOI 10.4045/tidsskr.24.0144, PubMed 38651719
  64. Shkodra M, Mulvey M, Fallon M, Brunelli C, Zecca E, Bracchi P, Caputo M, Massa G, Lo Dico S, Rolke R, Kaasa S, Caraceni A (2024)
    Application and accuracy of the EAPC/IASP diagnostic algorithm for neuropathic cancer pain and quantitative sensory testing profile in patients with pain due to cancer
    Pain Rep, 9 (2), e1140
    DOI 10.1097/PR9.0000000000001140, PubMed 38375093
  65. Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T (2024)
    Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
    Acta Oncol, 63, 83-94
    DOI 10.2340/1651-226X.2024.24970, PubMed 38501768
  66. Skipar K, Hompland T, Lund KV, Lindemann K, Hellebust TP, Bruheim K, Lyng H (2024)
    MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy
    Radiother Oncol, 195, 110263
    DOI 10.1016/j.radonc.2024.110263, PubMed 38556173
  67. Sodergren SC, Hurley-Wallace A, Vassiliou V, Alkhaffaf B, Batsaikhan B, Darlington AS, Fleitas-Kanonnikof T, Guren MG, Honda M, Kim YW, Kim S, Krishnamurthy MN, Loh SY, Turhal NS, Zhou J, Dennis K, Krishnatry R, Terashima M, Tsironis G, Yoshikawa T, Terada M, EORTC Quality of Life Group (2024)
    Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives
    Gastric Cancer (in press)
    DOI 10.1007/s10120-024-01492-8, PubMed 38668819
  68. Stoevesandt D, Ludwig C, Mauz-Körholz C, Körholz D, Hasenclever D, McCarten K, Flerlage JE, Kurch L, Wohlgemuth WA, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlén J, Cepelová M, Klekawka T, Attarbaschi A, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Steglich J (2024)
    Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging
    Pediatr Radiol, 54 (5), 725-736
    DOI 10.1007/s00247-024-05859-y, PubMed 38296856
  69. Stray K, Wibe T, Debesay J, Bye A (2024)
    Older adults' perceptions and experiences of interprofessional communication as part of the delivery of integrated care in the primary healthcare sector: a meta-ethnography of qualitative studies
    BMC Geriatr, 24 (1), 146
    DOI 10.1186/s12877-024-04745-4, PubMed 38347442
  70. Støyten M, Knutsen T, Stikbakke E, Agledahl I, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Thune I, Haugnes HS (2024)
    Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
    Acta Oncol, 63, 154-163
    DOI 10.2340/1651-226X.2024.32953, PubMed 38591351
  71. Svendsen K, Leithe S, Trewin-Nybråten CB, Balto A, Nes LS, Meland A, Børøsund E, Kiserud CE, Reinertsen KV, Eriksen HR, Gjelsvik YM, Ursin G (2024)
    How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?
    Cancers (Basel), 16 (3)
    DOI 10.3390/cancers16030602, PubMed 38339359
  72. Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
    3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
    Neuro Oncol (in press)
    DOI 10.1093/neuonc/noae037, PubMed 38452246
  73. Taskén K, F Haj Mohammad S, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H et al. (2024)
    PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
    Acta Oncol, 63, 385-391
    DOI 10.2340/1651-226X.2024.34791, PubMed 38779910
  74. Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
    CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
    Acta Neuropathol Commun, 12 (1), 55
    DOI 10.1186/s40478-023-01695-7, PubMed 38581034
  75. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2024)
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
    Int J Cancer, 154 (10), 1772-1785
    DOI 10.1002/ijc.34861, PubMed 38312044
  76. Torland LA, Lai X, Kumar S, Riis MH, Geisler J, Lüders T, Tekpli X, Kristensen V, Sahlberg K, Tahiri A (2024)
    Benign breast tumors may arise on different immunological backgrounds
    Mol Oncol (in press)
    DOI 10.1002/1878-0261.13655, PubMed 38757377
  77. Tulipan A, Kratochwil C, Lilleby J, Lilleby W (2024)
    A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer
    Urol Case Rep, 54, 102752
    DOI 10.1016/j.eucr.2024.102752, PubMed 38779691
  78. Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS, Cancer Cachexia Endpoints Working Group (2024)
    Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
    J Cachexia Sarcopenia Muscle, 15 (2), 513-535
    DOI 10.1002/jcsm.13434, PubMed 38343065
  79. van der Perk MEM, Broer L, Yasui Y, Laven JSE, Robison LL, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, van Dulmen-den Broeder E, Dirksen U, van der Pal HJ, de Vries ACH, Winther JF, Ranft A, Fosså SD, Grabow D, Muraca M et al. (2024)
    Inter-individual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE
    Fertil Steril (in press)
    DOI 10.1016/j.fertnstert.2024.05.002, PubMed 38729340
  80. Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heijden I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G (2024)
    Psychosocial factors associated with quality of life in cancer survivors: umbrella review
    J Cancer Res Clin Oncol, 150 (5), 249
    DOI 10.1007/s00432-024-05749-8, PubMed 38727730
  81. Western B, Ivarsson A, Vistad I, Demmelmaier I, Aaronson NK, Radcliffe G, van Beurden M, Bohus M, Courneya KS, Daley AJ, Galvão DA, Garrod R, Goedendorp MM, Griffith KA, van Harten WH, Hayes SC, Herrero-Roman F, Hiensch AE, Irwin ML, James E, Kenkhuis MF, Kersten MJ, Knoop H, Lucia A, May AM et al. (2024)
    Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study
    Scand J Med Sci Sports, 34 (2), e14575
    DOI 10.1111/sms.14575, PubMed 38339809
  82. Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE (2024)
    Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
    Nat Commun, 15 (1), 2810
    DOI 10.1038/s41467-024-47031-y, PubMed 38561347

Publications 2023

  1. Abadpour S, Niemi EM, Orrhult LS, Hermanns C, de Vries R, Nogueira LP, Haugen HJ, Josefsen D, Krauss S, Gatenholm P, van Apeldoorn A, Scholz H (2023)
    Adipose-Derived Stromal Cells Preserve Pancreatic Islet Function in a Transplantable 3D Bioprinted Scaffold
    Adv Healthc Mater, 12 (32), e2300640
    DOI 10.1002/adhm.202300640, PubMed 37781993
  2. Acosta Roa AM, Skingen VE, Rekstad BL, Undseth C, Rusten E, Hernes E, Guren MG, Malinen E (2023)
    Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer
    Phys Med, 114, 103151
    DOI 10.1016/j.ejmp.2023.103151, PubMed 37813051
  3. Albertsen PC, Bjerner LJ, Pasovic L, Müller S, Fosså S, Carlsson SV, Oldenburg J (2023)
    Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge
    BJU Int, 133 (1), 104-111
    DOI 10.1111/bju.16211, PubMed 37869764
  4. Alnes SR, Lærum-Onsager E, Bye A, Vistven A, Franzén E, Holst M, Brovold T (2023)
    Mobile health technology, exercise adherence and optimal nutrition post rehabilitation among people with Parkinson's Disease (mHEXANUT) - a randomized controlled trial protocol
    BMC Neurol, 23 (1), 93
    DOI 10.1186/s12883-023-03134-5, PubMed 36864377
  5. Amdal CD, Moan JM, Dale E, Falk RS, Johansen S, Bjordal K (2023)
    Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
    Clin Transl Radiat Oncol, 42, 100654
    DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
  6. Ascierto PA, Lipson EJ, Dummer R, Larkin J, Long GV, Sanborn RE, Chiarion-Sileni V, Dréno B, Dalle S, Schadendorf D, Callahan MK, Nyakas M, Atkinson V, Gomez-Roca CA, Yamazaki N, Tawbi HA, Sarkis N, Warad D, Dolfi S, Mitra P, Suryawanshi S, Grob JJ (2023)
    Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
    J Clin Oncol, 41 (15), 2724-2735
    DOI 10.1200/JCO.22.02072, PubMed 36780608
  7. Ask EH, Tschan-Plessl A, Hoel HJ, Kolstad A, Holte H, Malmberg KJ (2023)
    MetaGate: Interactive Analysis of High-Dimensional Cytometry Data with Meta Data Integration
    bioRxiv
    DOI 10.1101/2023.10.27.564454, PubMed 37961421
  8. Baech J, Husby S, Trab T, Kragholm K, Brown P, Gørløv JS, Jørgensen JM, Gudbrandsdottir S, Severinsen MT, Grønbaek K, Larsen TS, Wästerlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC (2023)
    Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study
    Br J Haematol, 204 (3), 967-975
    DOI 10.1111/bjh.19272, PubMed 38155503
  9. Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
    Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
    Clin Transl Radiat Oncol, 41, 100597
    DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
  10. Beck C, Casey NP, Persiconi I, Moharrami NN, Sike A, Jin Y, Kyte JA (2023)
    Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy
    Biomedicines, 11 (2)
    DOI 10.3390/biomedicines11020459, PubMed 36830995
  11. Berndsen M, Renberg S, Hølmebakk T, Hancke E, Puls F, Karlsson F, Stoldt S, Bjerkehagen B, Haglund de Flon F, Muth A, Papakonstantinou A, Boye K, Lindskog S (2023)
    Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
    Br J Surg, 110 (12), 1857-1862
    DOI 10.1093/bjs/znad309, PubMed 37758514
  12. Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
    Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
    Eur Urol (in press)
    DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639
  13. Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2023)
    Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
    Gynecol Oncol, 175, 72-80
    DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542
  14. Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
    Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
    PLoS One, 18 (2), e0281166
    DOI 10.1371/journal.pone.0281166, PubMed 36730349
  15. Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
    Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
    Neurooncol Pract, 11 (1), 36-45
    DOI 10.1093/nop/npad063, PubMed 38222046
  16. Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
    Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
    JCO Precis Oncol, 7, e2200351
    DOI 10.1200/PO.22.00351, PubMed 36724411
  17. Bratland Å, Munoz-Couselo E, Mortier L, Roshdy O, González R, Schachter J, Arance AM, Grange F, Meyer N, Joshi AJ, Billan S, Hughes BGM, Grob JJ, Ramakrishnan K, Ge J, Gumuscu B, Swaby RF, Gutzmer R (2023)
    Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
    Dermatol Ther (Heidelb), 13 (12), 3165-3180
    DOI 10.1007/s13555-023-01059-y, PubMed 37943491
  18. Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
    Editorial: Targeted alpha particle therapy in oncology
    Front Med (Lausanne), 10, 1165747
    DOI 10.3389/fmed.2023.1165747, PubMed 36960341
  19. Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
    Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
    J Hepatol, 79 (4), 955-966
    DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
  20. Bøhn S, Oldervoll LM, Reinertsen KV, Seland M, Fosså A, Kiserud C, Skaali T, Nilsen TS, Blomhoff R, Henriksen HB, Lie HC, Berge T, Fjerstad E, Wisløff T, Slott M, Zajmovic I, Thorsen L (2023)
    The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue
    Support Care Cancer, 32 (1), 22
    DOI 10.1007/s00520-023-08204-5, PubMed 38095797
  21. Børø S, Thoresen S, Boge Brant S, Helland Å (2023)
    Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer
    Acta Oncol, 62 (12), 1642-1648
    DOI 10.1080/0284186X.2023.2264484, PubMed 37801361
  22. Casey NP, Klee CH, Fåne A, Caulier B, Graczyk-Jarzynka A, Krawczyk M, Fidyt K, Josefsson SE, Köksal H, Dillard P, Patkowska E, Firczuk M, Smeland EB, Winiarska M, Myklebust JH, Inderberg EM, Wälchli S (2023)
    Efficient chimeric antigen receptor targeting of a central epitope of CD22
    J Biol Chem, 299 (7), 104883
    DOI 10.1016/j.jbc.2023.104883, PubMed 37269947
  23. Dahl AA, Bentzen AG, Fosså SD, Hess SL, Kiserud CE (2023)
    A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors
    Acta Obstet Gynecol Scand, 102 (2), 218-225
    DOI 10.1111/aogs.14490, PubMed 36683549
  24. Dahl AA, Smedsland SK, Vandraas KF, Bøhn SK, Falk RS, Kiserud CE, Reinertsen KV (2023)
    High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
    Breast Cancer Res Treat, 202 (1), 97-104
    DOI 10.1007/s10549-023-07055-2, PubMed 37528264
  25. Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Fosså A, Kiserud CE (2023)
    Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects
    J Cancer Surviv (in press)
    DOI 10.1007/s11764-023-01432-y, PubMed 37526861
  26. Dingemans AM, van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, van den Berg CA, Kaasa S (2023)
    High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study
    Nutrients, 15 (24)
    DOI 10.3390/nu15245030, PubMed 38140289
  27. Dueland S, Smedman TM, Syversveen T, Grut H, Hagness M, Line PD (2023)
    Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
    JAMA Surg, 158 (9), e232932
    DOI 10.1001/jamasurg.2023.2932, PubMed 37494056
  28. Eikeland SA, Smeland KB, Simensen VC, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2023)
    Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment
    Acta Oncol, 62 (1), 80-88
    DOI 10.1080/0284186X.2023.2168215, PubMed 36715320
  29. Elvebakken H, Hjortland GO, Garresori H, Andresen PA, Janssen EAM, Vintermyr OK, Lothe IMB, Sorbye H (2023)
    Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms
    J Neuroendocrinol, 35 (4), e13256
    DOI 10.1111/jne.13256, PubMed 37017614
  30. Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Glimelius I, Marklund A, Larsen TS, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
    Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study
    Br J Haematol, 202 (4), 785-795
    DOI 10.1111/bjh.18938, PubMed 37325886
  31. Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Molin D, Glimelius I, Marklund A, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
    Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
    Int J Cancer, 153 (4), 723-731
    DOI 10.1002/ijc.34552, PubMed 37119033
  32. Fallon MT, Caraceni A, Laird BJA, Kaasa S (2023)
    Reply to the Letter to the Editor "A simple way of doing the complex but utmost important things: cancer pain management" by S. Singhal, M. Verma and D. Kukreja
    Ann Oncol, 34 (5), 496-497
    DOI 10.1016/j.annonc.2023.02.005, PubMed 37121609
  33. Farnes I, Kleive D, Verbeke CS, Aabakken L, Issa-Epe A, Småstuen MC, Fosby BV, Dueland S, Line PD, Labori KJ (2023)
    Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2)
    BJS Open, 7 (6)
    DOI 10.1093/bjsopen/zrad137, PubMed 38155512
  34. Fauske L, Jebsen NL, Bondevik H, Bruland ØS (2023)
    Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
    Anticancer Res, 43 (5), 2031-2039
    DOI 10.21873/anticanres.16364, PubMed 37097689
  35. Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Nbcs Collaborators, Czene K, Devilee P, Dörk T et al. (2023)
    Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
    Cancers (Basel), 15 (13)
    DOI 10.3390/cancers15133313, PubMed 37444426
  36. Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
    WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
    Leukemia, 37 (9), 1842-1849
    DOI 10.1038/s41375-023-01980-3, PubMed 37507426
  37. Flølo TN, Fosså A, Nedkvitne JIP, Waage JER, Rekdal M, Dankel SN, Fernø J, Mellgren G, Nedrebø BG (2023)
    Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy
    Clin Obes, 13 (5), e12618
    DOI 10.1111/cob.12618, PubMed 37583310
  38. Foldvari Z, Knetter C, Yang W, Gjerdingen TJ, Bollineni RC, Tran TT, Lund-Johansen F, Kolstad A, Drousch K, Klopfleisch R, Leisegang M, Olweus J (2023)
    A systematic safety pipeline for selection of T-cell receptors to enter clinical use
    NPJ Vaccines, 8 (1), 126
    DOI 10.1038/s41541-023-00713-y, PubMed 37607971
  39. Fosså SD, Haugnes HS, Dahl AA, Kiserud CE, Fosså A, Skalleberg J, Myklebust TÅ (2023)
    Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
    Ann Oncol, 34 (12), 1165-1174
    DOI 10.1016/j.annonc.2023.09.3101, PubMed 37739265
  40. Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T et al. (2023)
    Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma
    Pediatr Blood Cancer, 70 (8), e30421
    DOI 10.1002/pbc.30421, PubMed 37243889
  41. Garset-Zamani M, von Buchwald C, Karevold G, Agander TK, Mateu-Regué À, Eide HA, Tvedskov JF (2023)
    An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
    JAMA Otolaryngol Head Neck Surg, 149 (1), 92-94
    DOI 10.1001/jamaoto.2022.3762, PubMed 36416857
  42. Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML et al. (2023)
    Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
    Eur J Cancer, 192, 113245
    DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
  43. Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
    Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
    BJU Int, 132 (3), 329-336
    DOI 10.1111/bju.16040, PubMed 37129962
  44. Gerdtsson AS, Matos Rodrigues J, Eskelund CW, Husby S, Grønbæk K, Räty R, Kolstad A, Geisler C, Porwit A, Jerkeman M, Ek S (2023)
    Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors
    Haematologica, 108 (4), 1092-1104
    DOI 10.3324/haematol.2022.281420, PubMed 36519324
  45. Gjerset GM, Kiserud CE, Wisløff T, McCarthy JB, Thorsen L (2023)
    Perceived burden and need for support among caregivers of cancer patients
    Acta Oncol, 62 (7), 794-802
    DOI 10.1080/0284186X.2023.2240008, PubMed 37540581
  46. Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A (2023)
    How I treat endocrine-dependent metastatic breast cancer
    ESMO Open, 8 (2), 100882
    DOI 10.1016/j.esmoop.2023.100882, PubMed 36806375
  47. Groendahl AR, Huynh BN, Tomic O, Søvik Å, Dale E, Malinen E, Skogmo HK, Futsaether CM (2023)
    Automatic gross tumor segmentation of canine head and neck cancer using deep learning and cross-species transfer learning
    Front Vet Sci, 10, 1143986
    DOI 10.3389/fvets.2023.1143986, PubMed 37026102
  48. Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
    Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
    Front Med (Lausanne), 10, 1058914
    DOI 10.3389/fmed.2023.1058914, PubMed 36844217
  49. Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
    The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
    Ann Hematol, 102 (4), 927-935
    DOI 10.1007/s00277-023-05149-x, PubMed 36864210
  50. Gulbrandsen MS, Nøding AS, Smeland KB, Eikeland SA, Kiserud CE, Hjermstad MJ, Fosså A (2023)
    Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma
    Leuk Lymphoma, 64 (6), 1139-1150
    DOI 10.1080/10428194.2023.2198053, PubMed 37144290
  51. Hanekamp BA, Viktil E, Slørdahl KS, Dormagen JB, Kløw NE, Malinen E, Brunborg C, Guren MG, Schulz A (2023)
    Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome
    Strahlenther Onkol, 200 (1), 19-27
    DOI 10.1007/s00066-023-02114-5, PubMed 37429949
  52. Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R (2023)
    Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
    JAMA Oncol, 9 (6), 779-789
    DOI 10.1001/jamaoncol.2023.0147, PubMed 37022706
  53. Haugen MH, von der Lippe Gythfeldt H, Egeland EV, Svartdal Normann L, Pandya AD, Vedin LL, Juell S, Tenstad E, Øy GF, Kristian A, Marangoni E, Sørlie T, Steffensen K, Maelandsmo GM, Engebraaten O (2023)
    Liver X receptors induce antiproliferative effects in basal-like breast cancer
    Mol Oncol, 17 (10), 2041-2055
    DOI 10.1002/1878-0261.13476, PubMed 37341140
  54. Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
    Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
    BMJ Open, 13 (3), e070071
    DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
  55. Helland Å, Myklebust TÅ, Conte S, Frederiksen LE, Aarøe J, Enerly E (2023)
    EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study
    Cancer Treat Res Commun, 38, 100785
    DOI 10.1016/j.ctarc.2023.100785, PubMed 38190787
  56. Hiensch AE, Beckhaus J, Witlox L, Monninkhof EM, Schagen SB, van Vulpen JK, Sweegers MG, Newton RU, Aaronson NK, Galvão DA, Steindorf K, Stuiver MM, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schulz KH, Schmidt ME, Ulrich CM, Sonke GS, van Harten WH, Winters-Stone KM, Velthuis MJ, Taaffe DR et al. (2023)
    Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis
    J Cancer Surviv (in press)
    DOI 10.1007/s11764-023-01392-3, PubMed 37160571
  57. Hindi N, Razak A, Rosenbaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DS et al. (2023)
    Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
    ESMO Open, 8 (6), 102045
    DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
  58. Hjelle LV, Sælen M, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Wilsgaard T, Fosså SD, Haugnes HS (2023)
    The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
    Eur Urol Open Sci, 53, 6-15
    DOI 10.1016/j.euros.2023.04.005, PubMed 37441342
  59. Hjermstad MJ, Aass N, Gravli TH, Smeland S, Kaasa S (2023)
    [Patient-centred cancer care]
    Tidsskr Nor Laegeforen, 143 (1)
    DOI 10.4045/tidsskr.22.0668, PubMed 36655956
  60. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
    A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
    Hepatology, 77 (3), 715-728
    DOI 10.1002/hep.32773, PubMed 36056902
  61. Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
    Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
    Hepatology, 77 (6), E188-E189
    DOI 10.1097/HEP.0000000000000340, PubMed 36815351
  62. Holm MO, Bye A, Falkmer U, Tobberup R, Rasmussen HH, Lauridsen C, Yilmaz MK, Søndergaard J, Poulsen LØ (2023)
    The effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review
    Crit Rev Oncol Hematol, 188, 104038
    DOI 10.1016/j.critrevonc.2023.104038, PubMed 37236410
  63. Holme IK, Hollund HA, Vandraas K, Kiserud CE, Reinertsen KV, Loge JH, Lie HC (2023)
    Sexual Problems as Late Effects: Awareness and Information Needs Among 1870 Long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
    J Adolesc Young Adult Oncol, 13 (1), 203-212
    DOI 10.1089/jayao.2023.0031, PubMed 37579257
  64. Huuhtanen J, Kasanen H, Peltola K, Lönnberg T, Glumoff V, Brück O, Dufva O, Peltonen K, Vikkula J, Jokinen E, Ilander M, Lee MH, Mäkelä S, Nyakas M, Li B, Hernberg M, Bono P, Lähdesmäki H, Kreutzman A, Mustjoki S (2023)
    Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma
    J Clin Invest, 133 (6)
    DOI 10.1172/JCI164809, PubMed 36719749
  65. Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2023)
    Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
    Front Med (Lausanne), 10, 1217037
    DOI 10.3389/fmed.2023.1217037, PubMed 37711738
  66. Huynh TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, Edin NFJ, Bjordal K, Herlofson BB, Kiserud CE, Helland Å, Amdal CD (2023)
    Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
    Radiother Oncol, 190, 110044
    DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
  67. Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA (2023)
    Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
    EBioMedicine, 97, 104829
    DOI 10.1016/j.ebiom.2023.104829, PubMed 37837931
  68. Isaksen KT, Galleberg R, Mastroianni MA, Rinde M, Rusten LS, Barzenje D, Ramslien F, Fluge O, Slaaen M, Meyer P, Liestol K, Smeland EB, Lingjarde OC, Holte H, Brodtkorb M (2023)
    The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
    Haematologica, 108 (9), 2454-2466
    DOI 10.3324/haematol.2022.282289, PubMed 36861406
  69. Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, Szumera-Ciećkiewicz A, Bobak K, Świtaj T, Rutkowski P, Czarnecka AM (2023)
    Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors
    Cancers (Basel), 15 (24)
    DOI 10.3390/cancers15245854, PubMed 38136399
  70. Jenul A, Stokmo HL, Schrunner S, Hjortland GO, Revheim ME, Tomic O (2023)
    Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival
    Comput Methods Programs Biomed, 244, 107934
    DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391
  71. Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
    Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
    Cells, 12 (5)
    DOI 10.3390/cells12050820, PubMed 36899955
  72. Joaquina S, Forcados C, Caulier B, Inderberg EM, Wälchli S (2023)
    Determination of CAR T cell metabolism in an optimized protocol
    Front Bioeng Biotechnol, 11, 1207576
    DOI 10.3389/fbioe.2023.1207576, PubMed 37409169
  73. Joensuu H, Wardelmann E, Eriksson M, Reichardt A, Hall KS, Schütte J, Cameron S, Hohenberger P, Sihto H, Jost PJ, Lindner LH, Bauer S, Nilsson B, Kallio R, Pesonen T, Reichardt P (2023)
    KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
    Clin Cancer Res, 29 (17), 3313-3319
    DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
  74. Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
    Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
    Front Med (Lausanne), 9, 1051825
    DOI 10.3389/fmed.2022.1051825, PubMed 36733936
  75. Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, Staiger AM, Kurz KS, Weigert O, Gaitzsch E, Passerini V, Engelhard M, Herfarth K, Beiske K, Micci F, Möller P, Bernd HW, Feller AC, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Holte H, Lenz G et al. (2023)
    Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
    Leukemia, 37 (10), 2058-2065
    DOI 10.1038/s41375-023-01995-w, PubMed 37563306
  76. Klee CH, Villatoro A, Casey NP, Inderberg EM, Wälchli S (2023)
    In vitro re-challenge of CAR T cells
    Methods Cell Biol, 183, 335-353
    DOI 10.1016/bs.mcb.2023.06.003, PubMed 38548418
  77. Knappskog S, Grob T, Venizelos A, Amstutz U, Hjortland GO, Lothe IM, Kersten C, Hofsli E, Sundlöv A, Elvebakken H, Garresori H, Couvelard A, Svensson J, Sorbye H, Perren A (2023)
    Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
    JCO Precis Oncol, 7, e2200336
    DOI 10.1200/PO.22.00336, PubMed 36753687
  78. Langberg CW, Horndalsveen H, Helland Å, Haakensen VD (2023)
    Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
    Front Oncol, 13, 1217424
    DOI 10.3389/fonc.2023.1217424, PubMed 37476372
  79. Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
    First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
    Front Med (Lausanne), 10, 1070362
    DOI 10.3389/fmed.2023.1070362, PubMed 36936230
  80. Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
    Arterial events in cancer patients treated with apixaban for venous thrombosis
    Thromb Res, 228, 128-133
    DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
  81. Le Tourneau C, André F, Helland Å, Mileshkin L, Minnaard W, Schiel A, Taskén K, Thomas DM, Veronese ML, Durán-Pacheco G, Leyens L, Rufibach K, Thomas M, Krämer A (2023)
    Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
    Eur J Cancer, 194, 113278
    DOI 10.1016/j.ejca.2023.113278, PubMed 37820553
  82. Leich E, Brodtkorb M, Schmidt T, Altenbuchinger M, Lingjærde OC, Lockmer S, Holte H, Nedeva T, Grieb T, Sander B, Sundström C, Spang R, Kimby E, Rosenwald A (2023)
    Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
    Leuk Lymphoma, 64 (12), 1927-1937
    DOI 10.1080/10428194.2023.2240462, PubMed 37683053
  83. Leivonen SK, Friman T, Autio M, Vaittinen S, Jensen AW, D'Amore F, Hamilton-Dutoit SJ, Holte H, Beiske K, Kovanen PE, Räty R, Leppä S (2023)
    Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
    Haematologica, 108 (11), 3044-3057
    DOI 10.3324/haematol.2023.282831, PubMed 37259566
  84. Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
    Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
    Neuropathology, 43 (5), 385-390
    DOI 10.1111/neup.12895, PubMed 36754566
  85. Lilleby W, Seierstad T, Inderberg EM, Hole KH (2023)
    Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring
    Int J Cancer, 152 (10), 2166-2173
    DOI 10.1002/ijc.34448, PubMed 36715014
  86. Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Hagen RK, Frøland AS, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB et al. (2023)
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
    Int J Radiat Oncol Biol Phys, 117 (5), 1222-1231
    DOI 10.1016/j.ijrobp.2023.06.246, PubMed 37423292
  87. Liu L, Choi J, Musoro JZ, Sauerbrei W, Amdal CD, Alanya A, Barbachano Y, Cappelleri JC, Falk RS, Fiero MH, Regnault A, Reijneveld JC, Sandin R, Thomassen D, Roychoudhury S, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2023)
    Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
    Lancet Oncol, 24 (5), e197-e206
    DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
  88. Lloret I, Hompland I, Lobmaier IV, Sundseth J, Server A (2023)
    Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation
    Neuroradiol J, 19714009231212358 (in press)
    DOI 10.1177/19714009231212358, PubMed 37923348
  89. Ludvigsen M, Campbell AJ, Enemark MB, Hybel TE, Karjalainen-Lindsberg ML, Beiske K, Bjerre M, Pedersen LM, Holte H, Leppä S, Jørgensen JM, Honoré B (2023)
    Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
    Blood Cancer J, 13 (1), 161
    DOI 10.1038/s41408-023-00931-6, PubMed 37884514
  90. Luminari S, Fossa A, Trotman J, Molin D, d'Amore F, Enblad G, Berkahn L, Barrington SF, Radford J, Federico M, Kirkwood AA, Johnson PWM (2023)
    Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
    J Clin Oncol, 42 (1), 13-18
    DOI 10.1200/JCO.23.01177, PubMed 37883739
  91. Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Dajani O, Mariussen KL, Steindal SA (2023)
    Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-based Palliative Care: Scoping Review
    J Med Internet Res, 25, e43429
    DOI 10.2196/43429, PubMed 36989024
  92. Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T et al. (2023)
    Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
    Lancet Oncol, 24 (3), 252-261
    DOI 10.1016/S1470-2045(23)00019-0, PubMed 36858722
  93. McDonald J, Sayers J, Anker SD, Arends J, Balstad TR, Baracos V, Brown L, Bye A, Dajani O, Dolan R, Fallon MT, Fraser E, Griel C, Grzyb A, Hjermstad M, Jamal-Hanjani M, Jakobsen G, Kaasa S, McMillan D, Maddocks M, Philips I, Ottestad IO, Reid KF, Sousa MS, Simpson MR et al. (2023)
    Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
    J Cachexia Sarcopenia Muscle, 14 (5), 1932-1948
    DOI 10.1002/jcsm.13321, PubMed 37671529
  94. Mediå LM, Sigurdardottir S, Fauske L, Waehre A (2023)
    Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
    Int J Qual Stud Health Well-being, 18 (1), 2204635
    DOI 10.1080/17482631.2023.2204635, PubMed 37092307
  95. Mendoza Mireles EE, Skaga E, Server A, Leske H, Brandal P, Helseth E, Rønning PA, Vik-Mo EO (2023)
    The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
    Neurooncol Pract, 10 (6), 555-564
    DOI 10.1093/nop/npad037, PubMed 38026582
  96. Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
    Nat Commun, 14 (1), 3375
    DOI 10.1038/s41467-023-39097-x, PubMed 37291203
  97. Mikalsen SG, Skjøtskift T, Flote VG, Hämäläinen NP, Heydari M, Rydén-Eilertsen K (2023)
    Extensive clinical testing of Deep Learning Segmentation models for thorax and breast cancer radiotherapy planning
    Acta Oncol, 62 (10), 1184-1193
    DOI 10.1080/0284186X.2023.2270152, PubMed 37883678
  98. Miranda R, Raemdonck E, Deliens L, Kaasa S, Zimmermann C, Rodin G, Robijn L, Lundeby T, Houbracken I, Beernaert K (2023)
    Do cancer centres and palliative care wards routinely measure patients' quality of life? An international cross-sectional survey study
    Support Care Cancer, 31 (8), 499
    DOI 10.1007/s00520-023-07964-4, PubMed 37523097
  99. Mo T, Brandal SHB, Geier OM, Engebråten O, Nilsen LB, Kristensen VN, Hole KH, Hompland T, Fleischer T, Seierstad T (2023)
    MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients
    Cancers (Basel), 15 (18)
    DOI 10.3390/cancers15184662, PubMed 37760629
  100. Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H (2023)
    Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
    Br J Cancer, 129 (12), 1930-1939
    DOI 10.1038/s41416-023-02462-0, PubMed 37872405
  101. Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
    Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
    Scand J Urol, 58, 101-108
    DOI 10.2340/sju.v58.5923, PubMed 37953521
  102. Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
    Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
    Mol Oncol, 17 (11), 2432-2450
    DOI 10.1002/1878-0261.13514, PubMed 37622176
  103. Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
    Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
    JMIR Res Protoc, 12, e45244
    DOI 10.2196/45244, PubMed 36920460
  104. Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
    Correction: Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
    JMIR Res Protoc, 12, e54462
    DOI 10.2196/54462, PubMed 37963373
  105. Nilssen Y, Solberg S, Brustugun OT, Møller B, Sundset A, Wahl SGF, Helland Å (2023)
    Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
    Eur J Cardiothorac Surg, 64 (1)
    DOI 10.1093/ejcts/ezad244, PubMed 37348858
  106. Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M (2023)
    Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
    Ann Oncol, 34 (11), 1015-1024
    DOI 10.1016/j.annonc.2023.08.010, PubMed 37657554
  107. Nilsson MP, Undseth C, Albertsson P, Eidem M, Havelund BM, Johannsson J, Johnsson A, Radu C, Serup-Hansen E, Spindler KL, Zakrisson B, Guren MG, Kronborg C (2023)
    Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
    Acta Oncol, 62 (8), 897-906
    DOI 10.1080/0284186X.2023.2240490, PubMed 37504978
  108. Niyoteka S, Seban RD, Rouhi R, Scarsbrook A, Genestie C, Classe M, Carré A, Sun R, La Greca Saint-Esteven A, Chargari C, McKenna J, McDermott G, Malinen E, Tanadini-Lang S, Guckenberger M, Guren MG, Lemanski C, Deutsch E, Robert C (2023)
    A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
    Eur J Nucl Med Mol Imaging, 50 (13), 4010-4023
    DOI 10.1007/s00259-023-06320-2, PubMed 37632562
  109. Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM (2023)
    High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
    PLoS One, 18 (1), e0280507
    DOI 10.1371/journal.pone.0280507, PubMed 36706086
  110. Oh DY, Algazi A, Capdevila J, Longo F, Miller W, Chun Bing JT, Bonilla CE, Chung HC, Guren TK, Lin CC, Motola-Kuba D, Shah M, Hadoux J, Yao L, Jin F, Norwood K, Lebellec L (2023)
    Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
    Cancer, 129 (8), 1195-1204
    DOI 10.1002/cncr.34657, PubMed 36748723
  111. Opheim LØ, Engeskaug I, Bjerre Trent PK, Thorsen L, Staff AC, Nordskar NJ, Utne I, Hagen M, Eriksson AGZ (2023)
    Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
    Gynecol Oncol, 179, 52-62
    DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595
  112. Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Van De Voorde L, Mach N, Bultijnck R, Fonteyne V, Moon D, Thon K et al. (2023)
    PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
    Eur Urol Oncol, 7 (3), 462-468
    DOI 10.1016/j.euo.2023.09.007, PubMed 37821242
  113. Otrebski Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Haug ES, Fosså SD, Johannesen TB (2023)
    Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
    Scand J Urol, 58, 133-140
    DOI 10.2340/sju.v58.14730, PubMed 38116675
  114. Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
    2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
    Front Neuroinform, 16, 1056068
    DOI 10.3389/fninf.2022.1056068, PubMed 36743439
  115. Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S (2023)
    Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)
    Cancer, 129 (22), 3564-3573
    DOI 10.1002/cncr.34964, PubMed 37530385
  116. Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V et al. (2023)
    Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
    N Engl J Med, 388 (18), 1645-1656
    DOI 10.1056/NEJMoa2212856, PubMed 37133584
  117. Pasetto A, Lu YC (2023)
    Editorial: Personalized immunotherapy for cancer
    Front Oncol, 13, 1171907
    DOI 10.3389/fonc.2023.1171907, PubMed 36959783
  118. Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM et al. (2023)
    Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
    Lancet Oncol, 24 (6), e270-e283
    DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
  119. Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L (2023)
    Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
    Front Oncol, 13, 1040665
    DOI 10.3389/fonc.2023.1040665, PubMed 36910663
  120. Piperno-Neumann S, Carlino MS, Boni V, Loirat D, Speetjens FM, Park JJ, Calvo E, Carvajal RD, Nyakas M, Gonzalez-Maffe J, Zhu X, Shirley MD, Ramkumar T, Fessehatsion A, Burks HE, Yerramilli-Rao P, Kapiteijn E (2023)
    A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
    Br J Cancer, 128 (6), 1040-1051
    DOI 10.1038/s41416-022-02133-6, PubMed 36624219
  121. Rakaee M, Andersen S, Giannikou K, Paulsen EE, Kilvaer TK, Busund LR, Berg T, Richardsen E, Lombardi AP, Adib E, Pedersen MI, Tafavvoghi M, Wahl SGF, Petersen RH, Bondgaard AL, Yde CW, Baudet C, Licht P, Lund-Iversen M, Grønberg BH, Fjellbirkeland L, Helland Å, Pøhl M, Kwiatkowski DJ, Donnem T (2023)
    Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
    Ann Oncol, 34 (7), 578-588
    DOI 10.1016/j.annonc.2023.04.005, PubMed 37100205
  122. Ramsower CA, Rosenthal A, Robetorye RS, Mwangi R, Maurer M, Villa D, McDonnell T, Feldman A, Cohen JB, Habermann T, Campo E, Clot G, Bühler MM, Kulis M, Martin-Subero JI, Giné E, Cook JR, Hill B, Raess PW, Beiske KH, Reichart A, Hartmann S, Holte H, Scott D, Rimsza L (2023)
    Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
    Br J Haematol, 204 (1), 160-170
    DOI 10.1111/bjh.19153, PubMed 37881141
  123. Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK (2023)
    N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells
    J Biol Chem, 300 (1), 105509
    DOI 10.1016/j.jbc.2023.105509, PubMed 38042493
  124. Riis ML, Augestad L, Flote VG, Tangerud A, Frich L (2023)
    Simultaneous cutaneous melanoma and ipsilateral breast cancer with metastasis to the same axilla. A case report with a focus on a multidisciplinary approach
    Int J Surg Case Rep, 114, 109119
    DOI 10.1016/j.ijscr.2023.109119, PubMed 38061088
  125. Riis RN, Riis MH, Benth JŠ, Augestad KM (2023)
    Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital
    Br J Surg, 110 (11), 1547-1548
    DOI 10.1093/bjs/znad275, PubMed 37672389
  126. Robert C, Carlino MS, McNeil C, Ribas A, Grob JJ, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance A, Daud AI, Hamid O, Larkin J, Anderson J, Krepler C, Grebennik D, Long GV (2023)
    Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma
    J Clin Oncol, 41 (24), 3998-4003
    DOI 10.1200/JCO.22.01599, PubMed 37348035
  127. Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023)
    Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway
    Acta Oncol, 62 (1), 8-14
    DOI 10.1080/0284186X.2023.2175331, PubMed 36762472
  128. Rohde M, Eriksen JG, Pareek M, Bratland Å, Mäkitie A, Hammarstedt-Nordenvall L, Wessel I, Lybeck JS, Mäenpää H, Gebre-Medhin M, Godballe C (2023)
    Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition
    Acta Oncol, 62 (9), 1102-1105
    DOI 10.1080/0284186X.2023.2245550, PubMed 37602835
  129. Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2023)
    Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
    Gastric Cancer, 26 (1), 167
    DOI 10.1007/s10120-022-01346-1, PubMed 36269499
  130. Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE (2023)
    Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
    Breast Cancer Res Treat, 204 (2), 249-259
    DOI 10.1007/s10549-023-07147-z, PubMed 38123789
  131. Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
    Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
    Cancer Res Commun, 3 (5), 884-895
    DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
  132. Salim R, Husby S, Winther Eskelund C, Scott DW, Holte H, Kolstad A, Räty R, Ek S, Jerkeman M, Geisler C, Sommer Kristensen L, Dahl M, Grønbæk K (2023)
    Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score
    Leuk Lymphoma, 64 (8), 1414-1423
    DOI 10.1080/10428194.2023.2216819, PubMed 37259807
  133. Sanchez VA, Shuey MM, Dinh PC, Monahan PO, Fosså SD, Sesso HD, Dolan ME, Einhorn LH, Vaughn DJ, Martin NE, Feldman DR, Kroenke K, Fung C, Frisina RD, Travis LB (2023)
    Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
    J Clin Oncol, 41 (12), 2211-2226
    DOI 10.1200/JCO.22.01456, PubMed 36626694
  134. Sars C, Sackey H, Frisell J, Dickman PW, Karlsson F, Kindts I, Marta GN, Freitas-Junior R, Tvedskov TF, Kassem L, Ali AS, Ihalainen H, Neron M, Kontos M, Kaidar-Person O, Meattini I, Francken AB, van Duijnhoven F, Moberg IO, Marinko T, Kollar A, Ahmed M, Remoundos D, Banks J, Jagsi R et al. (2023)
    Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
    Breast Cancer Res Treat, 199 (2), 293-304
    DOI 10.1007/s10549-023-06896-1, PubMed 36879102
  135. Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T (2023)
    [Glioblastoma in adults]
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.22.0314, PubMed 36718891
  136. Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT et al. (2023)
    Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
    J Clin Oncol, 41 (10), 1933-1942
    DOI 10.1200/JCO.22.01096, PubMed 36599120
  137. Schneider KM, Kummen M, Trivedi PJ, Hov JR (2023)
    Role of microbiome in autoimmune liver diseases
    Hepatology (in press)
    DOI 10.1097/HEP.0000000000000506, PubMed 37369002
  138. Shoushtari AN, Olszanski AJ, Nyakas M, Hornyak TJ, Wolchok JD, Levitsky V, Kuryk L, Hansen TB, Jäderberg M (2023)
    Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma
    Clin Cancer Res, 29 (1), 100-109
    DOI 10.1158/1078-0432.CCR-22-2046, PubMed 36112545
  139. Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2023)
    Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
    Eur J Surg Oncol, 50 (2), 107938
    DOI 10.1016/j.ejso.2023.107938, PubMed 38199004
  140. Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å (2023)
    New centres to carry out more clinical trials in Norway
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.22.0722, PubMed 36718905
  141. Skaali T, Blomhoff R, Lindemann K, Smeland S, Bruheim K, Seland M, Thorsen L (2023)
    Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life
    Acta Obstet Gynecol Scand, 103 (2), 387-395
    DOI 10.1111/aogs.14709, PubMed 37991142
  142. Sletten OJ, Aalen JM, Smiseth OA, Khan FH, Fossa A, Kiserud CE, Villegas-Martinez M, Hisdal J, Remme EW, Skulstad H (2023)
    Mental Stress Reduces Left Ventricular Strain: Can It Lead to Misinterpretation of Cancer Therapy-Related Cardiac Dysfunction?
    J Am Soc Echocardiogr, 37 (5), 564-566
    DOI 10.1016/j.echo.2023.11.010, PubMed 37981246
  143. Smedsland SK, Falk RS, Reinertsen KV, Kiserud CE, Brekke M, Bøhn SH, Dahl AA, Vandraas KF (2023)
    Burden of late effects in a nationwide sample of long-term breast cancer survivors
    Cancer, 130 (1), 140-149
    DOI 10.1002/cncr.35019, PubMed 37776533
  144. Smedsland SK, Vandraas KF, Falk RS, Horn J, Reidunsdatter RJ, Kiserud CE, Dahl AA, Brekke M, Reinertsen KV (2023)
    Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study
    Breast Cancer Res Treat, 201 (3), 479-488
    DOI 10.1007/s10549-023-07021-y, PubMed 37490170
  145. Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
    Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
    Ann Surg Oncol, 30 (12), 7602-7611
    DOI 10.1245/s10434-023-13964-9, PubMed 37481493
  146. Solmunde E, Falstie-Jensen AM, Lorenzen EL, Ewertz M, Reinertsen KV, Dekkers OM, Cronin-Fenton DP (2023)
    Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis
    Breast, 68, 216-224
    DOI 10.1016/j.breast.2023.02.008, PubMed 36868138
  147. Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, Lutgens LCHW, Hoskin P, Smet S, Pötter R, Nout R et al. (2023)
    Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
    Radiother Oncol, 181, 109501
    DOI 10.1016/j.radonc.2023.109501, PubMed 36720348
  148. Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
    Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
    Blood Adv, 7 (23), 7216-7230
    DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
  149. Storås AH, Tsuruda K, Fosså SD, Andreassen BK (2023)
    Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
    Acta Oncol, 62 (12), 1716-1722
    DOI 10.1080/0284186X.2023.2257876, PubMed 37725527
  150. Svendsen K, Nes LS, Meland A, Larsson IM, Gjelsvik YM, Børøsund E, Rygg CM, Myklebust TÅ, Reinertsen KV, Kiserud CE, Skjerven H, Antoni MH, Chalder T, Mjaaland I, Carlson LE, Eriksen HR, Ursin G (2023)
    Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions
    JMIR Res Protoc, 12, e47195
    DOI 10.2196/47195, PubMed 37103493
  151. Switlyk MD, Hopland A, Sivanesan S, Brennhovd B, Ottosson F, Berner K, Axcrona U, Hole KH (2023)
    Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings
    Eur J Radiol Open, 10, 100478
    DOI 10.1016/j.ejro.2023.100478, PubMed 36793771
  152. Sælen MG, Hjelle LV, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Fosså SD, Haugnes HS (2023)
    Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
    Acta Oncol, 62 (6), 657-665
    DOI 10.1080/0284186X.2023.2224051, PubMed 37353983
  153. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2023)
    Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
    Healthcare (Basel), 11 (6)
    DOI 10.3390/healthcare11060906, PubMed 36981562
  154. Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT et al. (2023)
    A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
    Cancer Immunol Immunother, 72 (7), 2357-2373
    DOI 10.1007/s00262-023-03421-7, PubMed 36939854
  155. Thorgersen EB, Asvall J, Schjalm C, McAdam KE, Bruland ØS, Larsen SG, Mollnes TE (2023)
    Effect of Intraperitoneal 224Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
    Technol Cancer Res Treat, 22, 15330338231192902
    DOI 10.1177/15330338231192902, PubMed 37574949
  156. Thorsen L, Courneya KS, Steene-Johannessen J, Gran JM, Haugnes HS, Negaard HFS, Kiserud CE, Fosså SD (2023)
    Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
    Int J Cancer, 153 (8), 1512-1519
    DOI 10.1002/ijc.34625, PubMed 37334652
  157. Tjelta J, Fjæra LF, Ytre-Hauge KS, Boer CG, Stokkevåg CH (2023)
    A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose
    Phys Med Biol, 68 (22)
    DOI 10.1088/1361-6560/ad0281, PubMed 37820690
  158. Trewin-Nybråten CB, Larsen IK, Møller B, Heikkilä R (2023)
    Hospital surgical volume and colorectal cancer survival in Norway: A nationwide cohort study
    Cancer Epidemiol, 85, 102404
    DOI 10.1016/j.canep.2023.102404, PubMed 37343490
  159. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
  160. Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
    Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
    Radiother Oncol, 187, 109810
    DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
  161. Upreti RP, Mmbaga E, Haugnes HS, Kiserud CE, Del Risco Kollerud R (2023)
    Most common health problems in general practice among adolescents, and young adults' survivors of lymphoma: a register-based cohort study in Norway
    Acta Oncol, 62 (12), 1607-1615
    DOI 10.1080/0284186X.2023.2273894, PubMed 37897712
  162. Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K (2023)
    Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
    Eur J Surg Oncol, 49 (9), 106958
    DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160
  163. van de Wal D, Fauske L, Bruland ØS, Jones RL, Kasper B, Wilson R, van der Graaf WTA, Husson O (2023)
    Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
    Support Care Cancer, 31 (6), 352
    DOI 10.1007/s00520-023-07810-7, PubMed 37233829
  164. van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N, FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials (2023)
    A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
    Cancer Treat Rev, 120, 102625
    DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
  165. Vandraas K, Reinertsen KV, Smedsland S, Bøhn S, Kiserud C, Falk RS, Lie HC (2023)
    Fear of cancer recurrence eight years after early-stage breast cancer - results from a national survey
    Acta Oncol, 62 (6), 635-641
    DOI 10.1080/0284186X.2023.2224052, PubMed 37337306
  166. Vandraas KF, Smedsland S, Engan HK, Kiserud C, Naume B, Brekke M, Reinertsen KV (2023)
    Late effects after breast cancer treatment
    Tidsskr Nor Laegeforen, 143 (11)
    DOI 10.4045/tidsskr.23.0017, PubMed 37589367
  167. Venizelos A, Sorbye H, Elvebakken H, Perren A, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Ladekarl M, Tabaksblat EM, Knappskog S (2023)
    Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Endocr Relat Cancer, 30 (10)
    DOI 10.1530/ERC-23-0057, PubMed 37410378
  168. Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
    Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
    Cardiovasc Res, 119 (10), 1915-1927
    DOI 10.1093/cvr/cvad078, PubMed 37216909
  169. Vittrup AS, Kirchheiner K, Pötter R, Fokdal LU, Jensen NBK, Spampinato S, Haie-Meder C, Schmid MP, Sturdza AE, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Wiebe E, van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Kirisits C, Lindegaard JC, Jürgenliemk-Schulz IM, Nout R, Tanderup K et al. (2023)
    Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
    Int J Radiat Oncol Biol Phys, 116 (4), 807-824
    DOI 10.1016/j.ijrobp.2023.01.002, PubMed 36641039
  170. Wallander K, Öfverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, Haglund de Flon F (2023)
    Sarcoma care in the era of precision medicine
    J Intern Med, 294 (6), 690-707
    DOI 10.1111/joim.13717, PubMed 37643281
  171. Wedde TB, Smaastuen MC, Vatne K, Schulz-Jaavall MB, Fosså SD, Lilleby WL (2023)
    External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
    Scand J Urol, 58, 68-75
    DOI 10.2340/sju.v58.9571, PubMed 37644904
  172. Wehrle CJ, Fujiki M, Schlegel A, Whitsett Linganna M, Pita A, Kim JK, Kwon DCH, Miller C, Hashimoto K, Dueland S, Sasaki K, Sapisochin G, Line PD, Hernandez-Alejandro R, Aucejo F (2023)
    Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'
    Ann Surg Oncol, 31 (2), 697-700
    DOI 10.1245/s10434-023-14611-z, PubMed 37996635
  173. Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
    Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
    JAMA Netw Open, 6 (3), e234149
    DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452
  174. Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
    Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
    Future Oncol, 19 (3), 205-215
    DOI 10.2217/fon-2022-0969, PubMed 36974621
  175. Winther RR, Skovlund E, Andreassen JS, Arvidsson L, Halvardson J, Solheim O, Bartek J, Kaasa S, Hjermstad MJ, Vik-Mo EO (2023)
    Preoperative Prognostic Index for Patients with Brain Metastases-A Population-Based Multi-Centre Study
    Cancers (Basel), 15 (12)
    DOI 10.3390/cancers15123174, PubMed 37370784
  176. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
    Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
    Med Phys, 50 (8), 5294
    DOI 10.1002/mp.16594, PubMed 37573581
  177. Åsberg RE, Nilsen M, Hjermstad MJ, Reinertsen KV, Karlsen J, Giskeødegård GF, Reidunsdatter RJ (2023)
    Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45
    Eur J Cancer, 190, 112943
    DOI 10.1016/j.ejca.2023.112943, PubMed 37515905

Publications 2022

  1. Abrantes R, Duarte HO, Gomes C, Wälchli S, Reis CA (2022)
    CAR-Ts: new perspectives in cancer therapy
    FEBS Lett, 596 (4), 403-416
    DOI 10.1002/1873-3468.14270, PubMed 34978080
  2. Achard V, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Meersschout S, Putora PM, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L et al. (2022)
    Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
    Radiother Oncol, 172, 1-9
    DOI 10.1016/j.radonc.2022.04.020, PubMed 35476942
  3. Amdal CD, Falk RS, Singer S, Pe M, Piccinin C, Bottomley A, Appiah LT, Arraras JI, Bayer O, Buanes EA, Darlington AS, Arbanas GD, Hofsø K, Holzner B, Sahlstrand-Johnson P, Kuliś D, Parmar G, Rmeileh NMEA, Schranz M, Sodergren S, Bjordal K (2022)
    A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
    Qual Life Res, 32 (2), 447-459
    DOI 10.1007/s11136-022-03272-2, PubMed 36273365
  4. Amdal CD, Taylor K, Kuliś D, Falk RS, Bottomley A, Arraras JI, Barte JH, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Mariano MP, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K (2022)
    Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
    J Patient Rep Outcomes, 6 (1), 26
    DOI 10.1186/s41687-022-00434-1, PubMed 35348945
  5. Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB (2022)
    Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
    Ear Hear, 43 (3), 794-807
    DOI 10.1097/AUD.0000000000001172, PubMed 35067571
  6. Bahadoer RR, Bastiaannet E, Peeters KCMJ, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2022)
    The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries
    J Geriatr Oncol, 13 (6), 803-812
    DOI 10.1016/j.jgo.2022.04.011, PubMed 35527207
  7. Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R (2022)
    PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
    J Immunother Cancer, 10 (1)
    DOI 10.1136/jitc-2021-002500, PubMed 35078921
  8. Barnes DJ, Dutton P, Bruland Ø, Gelderblom H, Faleti A, Bühnemann C, van Maldegem A, Johnson H, Poulton L, Love S, Tiemeier G, van Beelen E, Herbschleb K, Haddon C, Billingham L, Bradley K, Ferrari S, Palmerini E, Picci P, Dirksen U, Strauss SJ, Hogendoorn PCW, Buddingh E, Blay JY, Cleton-Jansen AM et al. (2022)
    Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
    BMC Cancer, 22 (1), 629
    DOI 10.1186/s12885-022-09697-9, PubMed 35672690
  9. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
    Melanoma - investigation and primary treatment
    Tidsskr Nor Laegeforen, 142 (15)
    DOI 10.4045/tidsskr.22.0043, PubMed 36286571
  10. Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
    Correction: Melanoma - investigation and primary treatment
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.22.0806, PubMed 36655962
  11. Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
    Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
    Front Immunol, 13, 875152
    DOI 10.3389/fimmu.2022.875152, PubMed 35911763
  12. Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
    Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
    Front Immunol, 13, 1051156
    DOI 10.3389/fimmu.2022.1051156, PubMed 36263024
  13. Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
    SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
    BMJ Case Rep, 15 (9)
    DOI 10.1136/bcr-2022-249599, PubMed 36167430
  14. Boye K, Lobmaier I, Kobbeltvedt MR, Thorkildsen J, Taksdal I, Bjerkehagen B, Bruland ØS, Zaikova O, Sundby Hall K, Hompland I (2022)
    Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
    Acta Oncol, 61 (7), 793-800
    DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
  15. Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
    Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
    Eur J Nutr, 61 (8), 3873-3885
    DOI 10.1007/s00394-022-02925-9, PubMed 35750881
  16. Burtness B, Rischin D, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Ge J, Swaby RF, Gumuscu B, Harrington K (2022)
    Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
    J Clin Oncol, 40 (21), 2321-2332
    DOI 10.1200/JCO.21.02198, PubMed 35333599
  17. Bye A, Bjerkeset E, Stensheim H, Loge JH, Hjermstad MJ, Klepstad P, Habberstad R, Kaasa S, Aass N (2022)
    Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
    Palliat Med Rep, 3 (1), 264-271
    DOI 10.1089/pmr.2022.0044, PubMed 36876292
  18. Bøhn SH, Vandraas KF, Kiserud CE, Dahl AA, Thorsen L, Ewertz M, Lie HC, Falk R, Reinertsen KV (2022)
    Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors
    J Cancer Surviv, 18 (2), 375-384
    DOI 10.1007/s11764-022-01202-2, PubMed 35314959
  19. Børø S, Thoresen S, Helland Å (2022)
    Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway
    Front Oncol, 12, 1017902
    DOI 10.3389/fonc.2022.1017902, PubMed 36523970
  20. Callesen LB, Hamfjord J, Boysen AK, Pallisgaard N, Guren TK, Kure EH, Spindler KG (2022)
    Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis
    Br J Cancer, 127 (3), 500-513
    DOI 10.1038/s41416-022-01816-4, PubMed 35440666
  21. Callesen LB, Takacova T, Hamfjord J, Würschmidt F, Oldhafer KJ, Brüning R, Arnold D, Spindler KG (2022)
    Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
    Ther Adv Med Oncol, 14, 17588359221133171
    DOI 10.1177/17588359221133171, PubMed 36339929
  22. Carlsson G, Koumarianou A, Guren TK, Haux J, Katsaounis P, Kentepozidis N, Pfeiffer P, Brændengen M, Mavroudis D, Taflin H, Skintemo L, Tell R, Papadimitriou C (2022)
    A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
    ESMO Open, 7 (5), 100589
    DOI 10.1016/j.esmoop.2022.100589, PubMed 36183444
  23. Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2022)
    Correction: Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
    Leukemia, 36 (4), 1198
    DOI 10.1038/s41375-022-01526-z, PubMed 35181760
  24. Dahl AA, Fosså SD (2022)
    High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
    Curr Oncol, 29 (8), 5823-5832
    DOI 10.3390/curroncol29080459, PubMed 36005197
  25. Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2022)
    A study of high neuroticism in long-term survivors of childhood, adolescence, and young adult cancers
    Sci Rep, 12 (1), 12325
    DOI 10.1038/s41598-022-15697-3, PubMed 35853946
  26. Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2022)
    Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
    Transplantation, 106 (1), e52-e63
    DOI 10.1097/TP.0000000000003762, PubMed 33741842
  27. Dijkstra EA, Hospers GAP, Kranenbarg EM, Fleer J, Roodvoets AGH, Bahadoer RR, Guren MG, Tjalma JJJ, Putter H, Crolla RMPH, Hendriks MP, Capdevila J, Radu C, van de Velde CJH, Nilsson PJ, Glimelius B, van Etten B, Marijnen CAM (2022)
    Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
    Radiother Oncol, 171, 69-76
    DOI 10.1016/j.radonc.2022.04.013, PubMed 35447283
  28. Dorraji E, Borgen E, Segura-Peña D, Rawat P, Smorodina E, Dunn C, Greiff V, Sekulić N, Russnes H, Kyte JA (2022)
    Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform
    Cancers (Basel), 14 (19)
    DOI 10.3390/cancers14194859, PubMed 36230782
  29. Dueland S, Smedman TM, Grut H, Syversveen T, Jørgensen LH, Line PD (2022)
    PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
    Cancers (Basel), 14 (20)
    DOI 10.3390/cancers14205042, PubMed 36291826
  30. Eide IJZ, Stensgaard S, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Sørensen BS, Brustugun OT (2022)
    Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
    Transl Lung Cancer Res, 11 (6), 953-963
    DOI 10.21037/tlcr-21-995, PubMed 35832438
  31. Eikeland SA, Smeland KB, Brekke M, Kiserud CE, Fosså A (2022)
    Late-effect awareness and follow-up of cancer in general practice
    Scand J Prim Health Care, 40 (3), 360-369
    DOI 10.1080/02813432.2022.2139457, PubMed 36380478
  32. Ellingsen EB, Bounova G, Kerzeli I, Anzar I, Simnica D, Aamdal E, Guren T, Clancy T, Mezheyeuski A, Inderberg EM, Mangsbo SM, Binder M, Hovig E, Gaudernack G (2022)
    Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
    J Transl Med, 20 (1), 419
    DOI 10.1186/s12967-022-03624-z, PubMed 36089578
  33. Ellingsen EB, Aamdal E, Guren T, Lilleby W, Brunsvig PF, Mangsbo SM, Aamdal S, Hovig E, Mensali N, Gaudernack G, Inderberg EM (2022)
    Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
    J Immunother Cancer, 10 (5)
    DOI 10.1136/jitc-2021-004345, PubMed 35613827
  34. Eriksen GF, Benth JŠ, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Oldervoll LM, Bye A, Hjelstuen A, Slaaen M (2022)
    Geriatric impairments are associated with reduced quality of life and physical function in older patients with cancer receiving radiotherapy - A prospective observational study
    J Geriatr Oncol, 14 (1), 101379
    DOI 10.1016/j.jgo.2022.09.008, PubMed 36180379
  35. Evensen H, Hjermstad MJ, Cvancarova M, Kristensen V, Larssen L, Skattum J, Hauge T, Sandstad O, Medhus AW (2022)
    Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy
    Endosc Int Open, 10 (12), E1570-E1576
    DOI 10.1055/a-1968-7682, PubMed 36531682
  36. Evensen ME, Furre T, Malinen E, Løndalen AM, Dale E (2022)
    Mucosa-sparing dose painting of head and neck cancer
    Acta Oncol, 61 (2), 141-145
    DOI 10.1080/0284186X.2021.2022200, PubMed 34991431
  37. Falk P, Severin M, Berglund Å, Guren MG, Hofsli E, Österlund P, Tandberg A, Eberhard J, Sorbye H (2022)
    Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
    Cancer Treat Res Commun, 31, 100517
    DOI 10.1016/j.ctarc.2022.100517, PubMed 35114500
  38. Fallon M, Dierberger K, Leng M, Hall PS, Allende S, Sabar R, Verastegui E, Gordon D, Grant L, Lee R, McWillams K, Murray GD, Norris L, Reid C, Sande TA, Caraceni A, Kaasa S, Laird BJA (2022)
    An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer
    Ann Oncol, 33 (12), 1296-1303
    DOI 10.1016/j.annonc.2022.08.083, PubMed 36055465
  39. Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
    Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
    Anticancer Res, 42 (2), 955-963
    DOI 10.21873/anticanres.15555, PubMed 35093895
  40. Forcados C, Joaquina S, Casey NP, Caulier B, Wälchli S (2022)
    How CAR T Cells Breathe
    Cells, 11 (9)
    DOI 10.3390/cells11091454, PubMed 35563759
  41. Fosså SD, Dahl AA, Johannesen TB, Gjelsvik YM, Storås AH, Myklebust TÅ (2022)
    Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
    Clin Transl Radiat Oncol, 37, 78-84
    DOI 10.1016/j.ctro.2022.08.003, PubMed 36093341
  42. Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ (2022)
    Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
    J Clin Oncol, 40 (23), 2588-2599
    DOI 10.1200/JCO.21.02105, PubMed 35380874
  43. Franco P, Segelov E, Johnsson A, Riechelmann R, Guren MG, Das P, Rao S, Arnold D, Spindler KG, Deutsch E, Krengli M, Tombolini V, Sebag-Montefiore D, De Felice F (2022)
    A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
    Cancers (Basel), 14 (7)
    DOI 10.3390/cancers14071697, PubMed 35406469
  44. Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
    Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
    J Clin Endocrinol Metab, 107 (5), e2141-e2147
    DOI 10.1210/clinem/dgab907, PubMed 34922379
  45. Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H et al. (2022)
    Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
    Br J Cancer, 127 (10), 1793-1798
    DOI 10.1038/s41416-022-01959-4, PubMed 36030294
  46. Gianinazzi ME, Kiserud CE, Ruud E, Lie HC (2022)
    Who Knows? Information Received, and Knowledge about, Cancer, Treatment and Late Effects in a National Cohort of Long-Term Childhood, Adolescent and Young Adult Cancer Survivors
    Cancers (Basel), 14 (6)
    DOI 10.3390/cancers14061534, PubMed 35326685
  47. Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B (2022)
    Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
    J Thorac Oncol, 18 (2), 181-193
    DOI 10.1016/j.jtho.2022.10.003, PubMed 36307040
  48. Gjerset GM, Skaali T, Seland M, Thorsen L (2022)
    Health-Related Quality of Life, Fatigue, Level of Physical Activity, and Physical Capacity Before and After an Outpatient Rehabilitation Program for Women Within Working Age Treated for Breast Cancer
    J Cancer Educ, 38 (3), 948-956
    DOI 10.1007/s13187-022-02211-6, PubMed 35974293
  49. Glatzer M, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos JA, Šegedin B, Cooper R, Nakken ES, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz IM, Niehoff P, Hermansson RS, Nout RA, Putora PM, Plasswilm L, Tselis N (2022)
    Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists
    Cancers (Basel), 14 (4)
    DOI 10.3390/cancers14040906, PubMed 35205653
  50. Gongora M, Stranne J, Johansson E, Bottai M, Thellenberg Karlsson C, Brasso K, Hansen S, Jakobsen H, Jäderling F, Lindberg H, Lilleby W, Meidahl Petersen P, Mirtti T, Olsson M, Rannikko A, Røder MA, Henrik Vincent P, Akre O (2022)
    Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
    Eur Urol Open Sci, 41, 63-73
    DOI 10.1016/j.euros.2022.04.013, PubMed 35813256
  51. Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
    Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
    Oncotarget, 13, 508-517
    DOI 10.18632/oncotarget.28209, PubMed 35284037
  52. Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
    [Checkpoint inhibitor-induced myocarditis]
    Tidsskr Nor Laegeforen, 142 (18)
    DOI 10.4045/tidsskr.21.0817, PubMed 36511752
  53. Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA (2022)
    Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
    Eur Urol Open Sci, 45, 68-75
    DOI 10.1016/j.euros.2022.09.002, PubMed 36353660
  54. Habberstad R, Aass N, Mollnes TE, Damås JK, Brunelli C, Rossi R, Garcia-Alonso E, Kaasa S, Klepstad P (2022)
    Inflammatory Markers and Radiotherapy Response in Patients With Painful Bone Metastases
    J Pain Symptom Manage, 64 (4), 330-339
    DOI 10.1016/j.jpainsymman.2022.06.018, PubMed 35803553
  55. Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Lin J, Gumuscu B, Swaby RF, Rischin D (2022)
    Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
    J Clin Oncol, 41 (4), 790-802
    DOI 10.1200/JCO.21.02508, PubMed 36219809
  56. Hauger SL, Borgen IMH, Løvstad M, Lu J, Forslund MV, Kleffelgård I, Andelic N, Røe C (2022)
    Community-Based Interventions After Acquired Brain Injury-A Systematic Review of Intervention Types and Their Effectiveness
    J Head Trauma Rehabil, 37 (5), E355-E369
    DOI 10.1097/HTR.0000000000000765, PubMed 35125426
  57. Helland Å, Andersen KK, Myklebust TÅ, Johannesen TB, Aarøe J, Enerly E (2022)
    EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway - A nationwide retrospective cohort study
    Cancer Treat Res Commun, 33, 100636
    DOI 10.1016/j.ctarc.2022.100636, PubMed 36155129
  58. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 225
    DOI 10.1186/s12967-022-03432-5, PubMed 35568909
  59. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 317
    DOI 10.1186/s12967-022-03518-0, PubMed 35841045
  60. Helliesen JS, Kristiansen I, Brekke HK, Støkket RS, Bye A (2022)
    Nutrition impact symptoms and the risk of malnutrition in people with Parkinson's disease: A cross-sectional study
    J Hum Nutr Diet, 36 (1), 40-50
    DOI 10.1111/jhn.13070, PubMed 35897145
  61. Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å (2022)
    Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial
    Mol Oncol, 17 (3), 487-498
    DOI 10.1002/1878-0261.13330, PubMed 36330681
  62. Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH (2022)
    Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
    J Immunol, 209 (10), 2042-2053
    DOI 10.4049/jimmunol.2200144, PubMed 36426942
  63. Hustad KS, Rundblad A, Ottestad I, Christensen JJ, Holven KB, Ulven SM (2022)
    Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study - CORRIGENDUM
    Br J Nutr, 128 (2), 367-368
    DOI 10.1017/S0007114522001519, PubMed 35579033
  64. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
    Idiopathic Duro-Optic Calcification
    J Neuroophthalmol, 44 (1), e204
    DOI 10.1097/WNO.0000000000001722, PubMed 36255093
  65. Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
    Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
    J Cancer Surviv, 17 (4), 1082-1093
    DOI 10.1007/s11764-022-01273-1, PubMed 36350483
  66. Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK (2022)
    Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
    Int J Mol Sci, 23 (7)
    DOI 10.3390/ijms23073714, PubMed 35409074
  67. Høye E, Dagenborg VJ, Torgunrud A, Lund-Andersen C, Fretland ÅA, Lorenz S, Edwin B, Hovig E, Fromm B, Inderberg EM, Greiff V, Ree AH, Flatmark K (2022)
    T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
    Gigascience, 12
    DOI 10.1093/gigascience/giad032, PubMed 37161965
  68. Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, Kiserud CE, Amdal CD (2022)
    Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
    J Cancer Surviv, 17 (2), 526-534
    DOI 10.1007/s11764-022-01311-y, PubMed 36509859
  69. Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles G, Schuster SJ, He F, Maziarz RT, Mayer S, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P et al. (2022)
    Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
    Blood Adv, 6 (16), 4816-4820
    DOI 10.1182/bloodadvances.2021006193, PubMed 35687492
  70. Jakobsen G, Gjeilo KH, Hjermstad MJ, Klepstad P (2022)
    An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer-Implications for Health Care Providers and Clinical Research
    Cancers (Basel), 14 (16)
    DOI 10.3390/cancers14163933, PubMed 36010925
  71. Jakobsen G, Sjue K, Paulsen Ø, Kaasa S, Hjermstad MJ, Klepstad P (2022)
    Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
    Support Care Cancer, 31 (1), 60
    DOI 10.1007/s00520-022-07537-x, PubMed 36534165
  72. Jespersen H (2022)
    Moles and melanoma
    Tidsskr Nor Laegeforen, 142 (15)
    DOI 10.4045/tidsskr.22.0626, PubMed 36286558
  73. Jin Y, Lorvik KB, Jin Y, Beck C, Sike A, Persiconi I, Kvaløy E, Saatcioglu F, Dunn C, Kyte JA (2022)
    Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
    Mol Ther Oncolytics, 26, 189-206
    DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
  74. Khadse A, Haakensen VD, Silwal-Pandit L, Hamfjord J, Micke P, Botling J, Brustugun OT, Lingjærde OC, Helland Å, Kure EH (2022)
    Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
    Front Oncol, 12, 873532
    DOI 10.3389/fonc.2022.873532, PubMed 35574381
  75. Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH (2022)
    Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer
    Lung Cancer, 166, 49-57
    DOI 10.1016/j.lungcan.2022.02.002, PubMed 35183991
  76. Kiserud CE, Lockmer S, Baerug I, Dahl AA, Kimby E, Østenstad B (2022)
    Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data
    Leuk Lymphoma, 64 (2), 349-355
    DOI 10.1080/10428194.2022.2142050, PubMed 36342349
  77. Kishan AU, Marco N, Schulz-Jaavall MB, Steinberg ML, Tran PT, Juarez JE, Dang A, Telesca D, Lilleby WA, Weidhaas JB (2022)
    Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation
    Radiother Oncol, 167, 226-232
    DOI 10.1016/j.radonc.2021.12.040, PubMed 34990726
  78. Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM et al. (2022)
    Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
    JAMA Oncol, 8 (3), e216871
    DOI 10.1001/jamaoncol.2021.6871, PubMed 35050303
  79. Kopetz S, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Belani A, Zhang X, Tabernero J (2022)
    Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
    ESMO Open, 7 (3), 100477
    DOI 10.1016/j.esmoop.2022.100477, PubMed 35653981
  80. Kosgallana S, Jayasekara P, Abeysinghe P, Hjermstad M, Lalloo R (2022)
    Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka
    BMC Oral Health, 22 (1), 359
    DOI 10.1186/s12903-022-02392-y, PubMed 35986341
  81. Kreye G, Lundeby T, Latino N, Galotti M, Kaasa S (2022)
    ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
    ESMO Open, 7 (6), 100622
    DOI 10.1016/j.esmoop.2022.100622, PubMed 36356414
  82. Kristensen A, Grønberg BH, Fløtten Ø, Kaasa S, Solheim TS (2022)
    Trajectory of health-related quality of life during the last year of life in patients with advanced non-small-cell lung cancer
    Support Care Cancer, 30 (11), 9351-9358
    DOI 10.1007/s00520-022-07359-x, PubMed 36109393
  83. Kryeziu K, Bergsland CH, Guren TK, Sveen A, Lothe RA (2022)
    Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars
    Biochim Biophys Acta Rev Cancer, 1877 (1), 188682
    DOI 10.1016/j.bbcan.2022.188682, PubMed 35065193
  84. Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
    Bone mineral density and nutrition in long-term survivors of childhood brain tumors
    Clin Nutr ESPEN, 50, 162-169
    DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
  85. Kyte JA (2022)
    Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
    Cancers (Basel), 14 (3)
    DOI 10.3390/cancers14030571, PubMed 35158839
  86. Kørner H, Guren MG, Larsen IK, Haugen DF, Søreide K, Kørner LR, Søreide JA (2022)
    Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients
    Eur J Surg Oncol, 48 (8), 1831-1839
    DOI 10.1016/j.ejso.2022.04.013, PubMed 35527055
  87. Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME (2022)
    Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    J Neuroendocrinol, 34 (7), e13170
    DOI 10.1111/jne.13170, PubMed 35729738
  88. Larsen BH, Lundeby T, Gulbrandsen P, Førde R, Gerwing J (2022)
    Physicians' responses to advanced cancer patients' existential concerns: A video-based analysis
    Patient Educ Couns, 105 (10), 3062-3070
    DOI 10.1016/j.pec.2022.06.007, PubMed 35738963
  89. Larsen EH, Mellblom AV, Larsen MH, Ruud E, Thorsen L, Petersen NN, Larsen HB, Fridh MK, Lie HC (2022)
    Perceived barriers and facilitators to physical activity in childhood cancer survivors and their parents: A large-scale interview study from the International PACCS Study
    Pediatr Blood Cancer, 70 (1), e30056
    DOI 10.1002/pbc.30056, PubMed 36251019
  90. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
    Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
    J Thromb Haemost, 20 (5), 1166-1181
    DOI 10.1111/jth.15666, PubMed 35114046
  91. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
    "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
    J Thromb Haemost, 20 (8), 1937-1939
    DOI 10.1111/jth.15774, PubMed 35859282
  92. Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
    [Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.22.0228, PubMed 36655971
  93. Lee CJ, Modave E, Boeckx B, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P (2022)
    Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial
    Int J Mol Sci, 23 (10)
    DOI 10.3390/ijms23105689, PubMed 35628499
  94. Lie HC, Anderssen S, Rueegg CS, Raastad T, Grydeland M, Thorsen L, Stensrud T, Edvardsen E, Larsen MH, Torsvik IK, Bovim LP, Götte M, Lähteenmäki PM, Kriemler S, Larsen HB, Fridh MK, Ørstavik K, Brun H, Matthews I, Hornset E, Ruud E (2022)
    The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study
    JMIR Res Protoc, 11 (3), e35838
    DOI 10.2196/35838, PubMed 35258456
  95. Lindegaard JC, Petric P, Schmid MP, Nesvacil N, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Kirchheiner K, Spampinato S, Jürgenliemk-Schulz I, Tanderup K, Kirisits C et al. (2022)
    Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
    Int J Radiat Oncol Biol Phys, 113 (2), 379-389
    DOI 10.1016/j.ijrobp.2022.02.005, PubMed 35157992
  96. Lofterød T, Frydenberg H, Veierød MB, Jenum AK, Reitan JB, Wist EA, Thune I (2022)
    The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study
    Acta Oncol, 61 (5), 649-657
    DOI 10.1080/0284186X.2022.2053573, PubMed 35348396
  97. Lunde P, Bye A, Bruusgaard KA, Hellem E, Nilsson BB (2022)
    Patients' Experiences of Using a Smartphone App After Cardiac Rehabilitation: Qualitative Study
    JMIR Hum Factors, 9 (1), e34294
    DOI 10.2196/34294, PubMed 35319476
  98. Lundeby T, Finset A, Kaasa S, Wester TE, Hjermstad MJ, Dajani O, Wist E, Aass N (2022)
    A complex communication skills training program for physicians providing advanced cancer care - content development and barriers and solutions for implementation
    J Commun Healthc, 16 (1), 46-57
    DOI 10.1080/17538068.2022.2039468, PubMed 36919800
  99. Lundeby T, Hjermstad MJ, Aass N, Kaasa S (2022)
    Integration of palliative care in oncology-the intersection of cultures and perspectives of oncology and palliative care
    Ecancermedicalscience, 16, 1376
    DOI 10.3332/ecancer.2022.1376, PubMed 35702405
  100. Lyng H, Skipar K, Hompland T (2022)
    Targeted Therapy on the Screen: Do We Hit the Target?
    Clin Cancer Res, 28 (24), 5233-5234
    DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006
  101. Løndalen A, Blakkisrud J, Revheim ME, Dahle J, Kolstad A, Stokke C (2022)
    FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
    Mol Imaging Biol, 24 (5), 807-817
    DOI 10.1007/s11307-022-01731-3, PubMed 35486292
  102. Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM (2022)
    A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
    Front Oncol, 12, 1031232
    DOI 10.3389/fonc.2022.1031232, PubMed 36439452
  103. Marabelle A, Cassier PA, Fakih M, Kao S, Nielsen D, Italiano A, Guren TK, van Dongen MGJ, Spencer K, Bariani GM, Ascierto PA, Santoro A, Shah M, Asselah J, Iqbal S, Takahashi S, Piha-Paul SA, Ott PA, Chatterjee A, Jin F, Norwood K, Delord JP (2022)
    Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
    Lancet Gastroenterol Hepatol, 7 (5), 446-454
    DOI 10.1016/S2468-1253(21)00382-4, PubMed 35114169
  104. Mediå LM, Fauske L, Sigurdardottir S, Feragen KJB, Heggeli C, Wæhre A (2022)
    'It was Supposed to be a Secret': a study of disclosure and stigma as experienced by adults with differences of sex development
    Health Psychol Behav Med, 10 (1), 579-595
    DOI 10.1080/21642850.2022.2102018, PubMed 35898596
  105. Meltzer S, Negård A, Bakke KM, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2022)
    Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
    Br J Cancer, 127 (12), 2227-2233
    DOI 10.1038/s41416-022-02004-0, PubMed 36229579
  106. Mensali N, Inderberg EM (2022)
    Emerging Biomarkers for Immunotherapy in Glioblastoma
    Cancers (Basel), 14 (8)
    DOI 10.3390/cancers14081940, PubMed 35454848
  107. Meriranta L, Alkodsi A, Pasanen A, Lepistö M, Mapar P, Blaker YN, Jørgensen J, Karjalainen-Lindsberg ML, Fiskvik I, Mikalsen LTG, Autio M, Björkholm M, Jerkeman M, Fluge Ø, Brown P, Jyrkkiö S, Holte H, Pitkänen E, Ellonen P, Leppä S (2022)
    Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
    Blood, 139 (12), 1863-1877
    DOI 10.1182/blood.2021012852, PubMed 34932792
  108. Merklinger-Gruchala A, Jasienska G, Thune I, Kapiszewska M (2022)
    Joint effect of particulate matter and cigarette smoke on women's sex hormones
    BMC Womens Health, 22 (1), 3
    DOI 10.1186/s12905-021-01586-w, PubMed 34996432
  109. Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
    Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
    J Infect Dis, 225 (4), 661-674
    DOI 10.1093/infdis/jiaa714, PubMed 33216130
  110. Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
    Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
    J Acquir Immune Defic Syndr, 89 (1), 77-86
    DOI 10.1097/QAI.0000000000002817, PubMed 34878437
  111. Mo T, Brandal SHB, Köhn-Luque A, Engebraaten O, Kristensen VN, Fleischer T, Hompland T, Seierstad T (2022)
    Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer
    Cancers (Basel), 14 (5)
    DOI 10.3390/cancers14051326, PubMed 35267636
  112. Monsen KV, Fosså SD, Myklebust TÅ, Smeland S, Dahl AA, Stensvold A (2022)
    Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors
    Acta Oncol, 61 (3), 357-362
    DOI 10.1080/0284186X.2021.2006775, PubMed 35103559
  113. Mucci LA, Vinson J, Gold T, Gerke T, Filipenko J, Green RM, Anderson SG, Badal S, Bjartell A, Chi KN, Davis ID, Enting D, Fay AP, Lazarus J, Mateo J, McDermott R, Odedina FT, Olmos D, Omlin A, Popoola AA, Ragin C, Roberts R, Russnes KM, Waihenya C, Stopsack KH et al. (2022)
    IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
    JCO Glob Oncol, 8, e2200154
    DOI 10.1200/GO.22.00154, PubMed 36332173
  114. Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
    Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
    Scand J Urol, 56 (3), 214-220
    DOI 10.1080/21681805.2022.2056633, PubMed 35506475
  115. Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
    Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
    BMC Cancer, 22 (1), 1301
    DOI 10.1186/s12885-022-10394-w, PubMed 36510166
  116. Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen GH, Due-Tønnessen B, Frič R, Nilssen Y, Brandal P (2022)
    Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017
    Pediatr Blood Cancer, 69 (9), e29736
    DOI 10.1002/pbc.29736, PubMed 35570402
  117. Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, Dankel SN, Gudbrandsen OA, Fernø J, Hjellestad I, Hjermstad MJ, Kolotkin RL, Thorsen HL, Mellgren G, Flølo TN (2022)
    Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy
    Int J Obes (Lond), 46 (4), 739-749
    DOI 10.1038/s41366-021-01028-5, PubMed 34974544
  118. Nilsen TS, Johansen SH, Thorsen L, Fairman CM, Wisløff T, Raastad T (2022)
    Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
    Int J Environ Res Public Health, 19 (7)
    DOI 10.3390/ijerph19073820, PubMed 35409505
  119. Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
    Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
    BMC Cancer, 22 (1), 220
    DOI 10.1186/s12885-022-09306-9, PubMed 35227226
  120. Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, Villegas F, Gagliardi G, Hellström M, Wang QL, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-Haidari G, Rekstad LC, Aahlin EK, Wallner B, Edholm D, Johansson J, Szabo E, Reynolds JV, Pramesh CS, Mummudi N, Joshi A et al. (2022)
    Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
    Front Oncol, 12, 917961
    DOI 10.3389/fonc.2022.917961, PubMed 35912196
  121. Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
    Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
    Acta Oncol, 61 (3), 385
    DOI 10.1080/0284186X.2021.2023214, PubMed 35037554
  122. Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
    AXL inhibition improves BRAF-targeted treatment in melanoma
    Sci Rep, 12 (1), 5076
    DOI 10.1038/s41598-022-09078-z, PubMed 35332208
  123. Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L (2022)
    Merkel cell carcinoma
    Tidsskr Nor Laegeforen, 142 (9)
    DOI 10.4045/tidsskr.21.0693, PubMed 35699540
  124. Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2022)
    Correction to: A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
    Eur Geriatr Med, 13 (5), 1231-1232
    DOI 10.1007/s41999-022-00653-1, PubMed 35524006
  125. Osong B, Masciocchi C, Damiani A, Bermejo I, Meldolesi E, Chiloiro G, Berbee M, Lee SH, Dekker A, Valentini V, Gerard JP, Rödel C, Bujko K, van de Velde C, Folkesson J, Sainato A, Glynne-Jones R, Ngan S, Brændengen M, Sebag-Montefiore D, van Soest J (2022)
    Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery
    Phys Imaging Radiat Oncol, 22, 1-7
    DOI 10.1016/j.phro.2022.03.002, PubMed 35372704
  126. Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP et al. (2022)
    External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
    Int J Radiat Oncol Biol Phys, 115 (3), 645-653
    DOI 10.1016/j.ijrobp.2022.09.075, PubMed 36179990
  127. Paur I, Smedshaug GB, Haugum B, Bye A, Eliassen E, Flottorp TL, Juul HJ, Mowe M, Nakken T, Ore S, Sirevåg GK, Sygnestveit K, Thoresen L, Aasen EB, Totland TH, Krogh HW (2022)
    The Norwegian Directorate of Health recommends malnutrition screening tool (MST) for all adults
    Clin Nutr ESPEN, 52, 28-31
    DOI 10.1016/j.clnesp.2022.09.029, PubMed 36513467
  128. Pierson SK, Katz L, Williams R, Mumau M, Gonzalez M, Guzman S, Rubenstein A, Oromendia AB, Beineke P, Fosså A, van Rhee F, Fajgenbaum DC (2022)
    CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
    Nat Commun, 13 (1), 7236
    DOI 10.1038/s41467-022-34873-7, PubMed 36433996
  129. Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J et al. (2022)
    Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
    Neuro Oncol, 24 (5), 755-767
    DOI 10.1093/neuonc/noab243, PubMed 34672349
  130. Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
    Fibrinogen-like protein 2 in gastrointestinal stromal tumour
    J Cell Mol Med, 26 (4), 1083-1094
    DOI 10.1111/jcmm.17163, PubMed 35029030
  131. Rao S, Anandappa G, Capdevila J, Dahan L, Evesque L, Kim S, Saunders MP, Gilbert DC, Jensen LH, Samalin E, Spindler KL, Tamberi S, Demols A, Guren MG, Arnold D, Fakih M, Kayyal T, Cornfeld M, Tian C, Catlett M, Smith M, Spano JP (2022)
    A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
    ESMO Open, 7 (4), 100529
    DOI 10.1016/j.esmoop.2022.100529, PubMed 35816951
  132. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
  133. Riis M, Csanaky G, Lehne G, Tangerud A (2022)
    Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations
    BMJ Case Rep, 15 (3)
    DOI 10.1136/bcr-2021-248232, PubMed 35236698
  134. Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
    Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
    Br J Haematol, 197 (6), 697-708
    DOI 10.1111/bjh.18149, PubMed 35254660
  135. Rimstad R, Løkkevik E, Juul-Hansen KE, Holtan A (2022)
    Patient needs in evacuation of a tertiary oncology center
    J Emerg Manag, 20 (3), 267-272
    DOI 10.5055/jem.0626, PubMed 35792815
  136. Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B (2022)
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
    Oral Oncol, 128, 105815
    DOI 10.1016/j.oraloncology.2022.105815, PubMed 35381576
  137. Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2022)
    Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
    Gastric Cancer, 25 (4), 665-677
    DOI 10.1007/s10120-022-01309-6, PubMed 35689705
  138. Ryg U, Seierstad T, Nilsen LB, Hellebust TP, Djupvik LH, Gustafson H, Hydal J, Kishan AU, Hole KH, Lilleby W (2022)
    A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
    Front Oncol, 12, 861127
    DOI 10.3389/fonc.2022.861127, PubMed 35463376
  139. Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA (2022)
    Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
    Nat Med, 28 (12), 2573-2583
    DOI 10.1038/s41591-022-02126-1, PubMed 36482103
  140. Schei S, Solheim O, Salvesen Ø, Hjermstad MJ, Bouget D, Sagberg LM (2022)
    Pretreatment patient-reported cognitive function in patients with diffuse glioma
    Acta Neurochir (Wien), 164 (3), 703-711
    DOI 10.1007/s00701-022-05126-9, PubMed 35142918
  141. Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K (2022)
    Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes
    Cancers (Basel), 14 (24)
    DOI 10.3390/cancers14246045, PubMed 36551530
  142. Schou-Bredal I, Sørensen EM, Kraglund KH, Jensen VS, Drageset S (2022)
    Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments
    Patient Relat Outcome Meas, 13, 199-208
    DOI 10.2147/PROM.S364625, PubMed 36238534
  143. Segelov E, Guren MG, Sebag-Montefiore D, Rao S, Johnsson A, Franco P, Deutsch E, Arnold D, Spindler KG (2022)
    "Global Multidisciplinary Team Meetings": Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)
    Clin Colorectal Cancer, 21 (3), 175-187
    DOI 10.1016/j.clcc.2022.02.006, PubMed 35346604
  144. Seidensaal K, Dostal M, Liermann J, Adeberg S, Weykamp F, Schmid MP, Freudlsperger C, Hoffmann J, Hompland I, Herfarth K, Debus J, Harrabi SB (2022)
    Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
    Front Oncol, 12, 927399
    DOI 10.3389/fonc.2022.927399, PubMed 36212490
  145. Shkodra M, Brunelli C, Zecca E, Infante G, Miceli R, Caputo M, Bracchi P, Lo Dico S, Kaasa S, Caraceni A (2022)
    Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment
    Palliat Med, 36 (9), 1396-1407
    DOI 10.1177/02692163221122354, PubMed 36113091
  146. Silva DN, Chrobok M, Ahlén G, Blomberg P, Sällberg M, Pasetto A (2022)
    ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
    Immunooncol Technol, 16, 100099
    DOI 10.1016/j.iotech.2022.100099, PubMed 36389443
  147. Skipar K, Hompland T, Lund KV, Løndalen A, Malinen E, Kristensen GB, Lindemann K, Nakken ES, Bruheim K, Lyng H (2022)
    Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
    Radiother Oncol, 176, 17-24
    DOI 10.1016/j.radonc.2022.09.002, PubMed 36113778
  148. Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
    Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
    Breast Care (Basel), 17 (5), 486-494
    DOI 10.1159/000524564, PubMed 36684407
  149. Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2022)
    Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women
    Eur J Surg Oncol, 49 (3), 575-582
    DOI 10.1016/j.ejso.2022.11.594, PubMed 36509629
  150. Skåre TS, Midtbust MH, Lund JÅ, Kaasa S, Dreyer A (2022)
    Barriers and Facilitators When Implementing Electronic Patient-Reported Outcome Measures at a Municipal Cancer Care Unit: A Qualitative Study
    Cancer Nurs, 46 (4), E268-E275
    DOI 10.1097/NCC.0000000000001120, PubMed 35439218
  151. Smedman TM, Guren TK, Tveit KM, Thomsen M, Andersen MH, Line PD, Dueland S (2022)
    Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
    Transpl Int, 35, 10404
    DOI 10.3389/ti.2022.10404, PubMed 35707633
  152. Smedsland SK, Vandraas KF, Bøhn SK, Dahl AA, Kiserud CE, Brekke M, Falk RS, Reinertsen KV (2022)
    Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey
    Breast Cancer Res Treat, 193 (1), 139-149
    DOI 10.1007/s10549-022-06544-0, PubMed 35226237
  153. Smeland K, Holte H, Fagerli UM, Bersvendsen H, Hjermstad MJ, Loge JH, Murbrach K, Linnsund MD, Fluge O, Stenehjem JS, Lund MB, Kvaloy S, Kiserud CE (2022)
    Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
    Haematologica, 107 (11), 2698-2707
    DOI 10.3324/haematol.2021.280413, PubMed 35484681
  154. Sodergren SC, Johnson CD, Gilbert A, Darlington AS, Cocks K, Guren MG, Rivin Del Campo E, Brannan C, Christensen P, Chu W, Chung H, Dennis K, Desideri I, Gilbert DC, Glynne-Jones R, Jefford M, Johansson M, Johnsson A, Juul T, Kardamakis D, Lai-Kwon J, McFarlane V, Miguel IMC, Nugent K, Peters F et al. (2022)
    International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
    Int J Radiat Oncol Biol Phys, 115 (5), 1155-1164
    DOI 10.1016/j.ijrobp.2022.11.002, PubMed 36402360
  155. Solberg S, Nilssen Y, Terje Brustugun O, Magnus Haram P, Helland Å, Møller B, Strand TE, Gyrid Freim Wahl S, Fjellbirkeland L (2022)
    Concordance between clinical and pathology TNM-staging in lung cancer
    Lung Cancer, 171, 65-69
    DOI 10.1016/j.lungcan.2022.07.014, PubMed 35926242
  156. Solheim JM, Dueland S, Line PD, Hagness M (2022)
    Transplantation for Nonresectable Colorectal Liver Metastases: Long-Term Follow-Up of the First Prospective Pilot Study
    Ann Surg, 278 (2), 239-245
    DOI 10.1097/SLA.0000000000005703, PubMed 36082986
  157. Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL et al. (2022)
    Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
    Cancer Treat Rev, 112, 102491
    DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
  158. Stalsberg R, Bertheussen GF, Børset H, Thomsen SN, Husøy A, Flote VG, Thune I, Lundgren S (2022)
    Do Breast Cancer Patients Manage to Participate in an Outdoor, Tailored, Physical Activity Program during Adjuvant Breast Cancer Treatment, Independent of Health and Socio-Demographic Characteristics?
    J Clin Med, 11 (3)
    DOI 10.3390/jcm11030843, PubMed 35160292
  159. Steinberg MF, Olsen JA, Persse D, Souders CM, Wik L (2022)
    Efficacy of defibrillator pads placement during ventricular arrhythmias, a before and after analysis
    Resuscitation, 174, 16-19
    DOI 10.1016/j.resuscitation.2022.03.004, PubMed 35276312
  160. Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
    Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
    Cancers (Basel), 14 (11)
    DOI 10.3390/cancers14112784, PubMed 35681766
  161. Stikbakke E, Wilsgaard T, Haugnes HS, Pedersen MI, Knutsen T, Støyten M, Giovannucci E, Eggen AE, Thune I, Richardsen E (2022)
    Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
    Cancers (Basel), 14 (5)
    DOI 10.3390/cancers14051142, PubMed 35267449
  162. Storm-Larsen C, Hande LN, Kummen M, Thunhaug H, Vestad B, Hansen SH, Hovland A, Trøseid M, Lappegård KT, Hov JR (2022)
    Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial
    Scand J Clin Lab Invest, 82 (5), 363-370
    DOI 10.1080/00365513.2022.2102540, PubMed 35913798
  163. Storås AH, Andreassen BK, Fosså SD (2022)
    Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
    Acta Oncol, 61 (5), 615-618
    DOI 10.1080/0284186X.2022.2051204, PubMed 35300560
  164. Strømsvik N, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Jørgensen K, Wangensteen T, Vamre T, Heramb C, Mæhle L, Grindedal EM (2022)
    "It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing
    Hered Cancer Clin Pract, 20 (1), 6
    DOI 10.1186/s13053-022-00212-6, PubMed 35123550
  165. Staaf J, Häkkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, Lien T, Sørlie T, Naume B, Russnes H, Marcone R, Ayyanan A, Brisken C, Malterling RR, Asking B, Olofsson H, Lindman H, Bendahl PO, Ehinger A, Larsson C, Loman N, Rydén L, Malmberg M, Borg Å, Vallon-Christersson J (2022)
    RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
    NPJ Breast Cancer, 8 (1), 94
    DOI 10.1038/s41523-022-00465-3, PubMed 35974007
  166. Svestad JG, Heydari M, Mikalsen SG, Flote VG, Nordby F, Hellebust TP (2022)
    Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial
    Radiother Oncol, 177, 46-52
    DOI 10.1016/j.radonc.2022.10.017, PubMed 36309152
  167. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
    Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
    Support Care Cancer, 30 (12), 10233-10241
    DOI 10.1007/s00520-022-07405-8, PubMed 36307656
  168. Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
    Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
    Support Care Cancer, 30 (7), 6155-6162
    DOI 10.1007/s00520-022-07048-9, PubMed 35426047
  169. Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES, CONNECT Public–Private Partnership Consortium, Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R, InPreD-Norway and National Molecular Tumor Board Consortium, IMPRESS-Norway Consortium, Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å (2022)
    A national precision cancer medicine implementation initiative for Norway
    Nat Med, 28 (5), 885-887
    DOI 10.1038/s41591-022-01777-4, PubMed 35513529
  170. Theophanous S, Lønne PI, Choudhury A, Berbee M, Dekker A, Dennis K, Dewdney A, Gambacorta MA, Gilbert A, Guren MG, Holloway L, Jadon R, Kochhar R, Mohamed AA, Muirhead R, Parés O, Raszewski L, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Spindler KG, van Triest B, Vassiliou V, Malinen E et al. (2022)
    Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
    Diagn Progn Res, 6 (1), 14
    DOI 10.1186/s41512-022-00128-8, PubMed 35922837
  171. Tonkopi E, Wikan EJ, Hovland TO, Høgset S, Kofod TA, Sefenu SK, Hughes-Ryan E, D Entremont-O Connell D, Gunn C, Holter T, Johansen S (2022)
    A survey of local diagnostic reference levels for the head, thorax, abdomen and pelvis computed tomography in Norway and Canada
    Acta Radiol Open, 11 (10), 20584601221131477
    DOI 10.1177/20584601221131477, PubMed 36225897
  172. Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
    Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
    Front Med (Lausanne), 9, 1058863
    DOI 10.3389/fmed.2022.1058863, PubMed 36507500
  173. Totland TH, Krogh HW, Smedshaug GB, Tornes RA, Bye A, Paur I (2022)
    Harmonization and standardization of malnutrition screening for all adults - A systematic review initiated by the Norwegian Directorate of Health
    Clin Nutr ESPEN, 52, 32-49
    DOI 10.1016/j.clnesp.2022.09.028, PubMed 36513471
  174. Umu SU, Langseth H, Zuber V, Helland Å, Lyle R, Rounge TB (2022)
    Serum RNAs can predict lung cancer up to 10 years prior to diagnosis
    Elife, 11
    DOI 10.7554/eLife.71035, PubMed 35147498
  175. Vajavaara H, Leivonen SK, Jørgensen J, Holte H, Leppä S (2022)
    Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma
    EJHaem, 3 (3), 681-687
    DOI 10.1002/jha2.409, PubMed 36051040
  176. van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L et al. (2022)
    Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
    Endocr Rev, 43 (5), 794-823
    DOI 10.1210/endrev/bnab040, PubMed 34962573
  177. Vandraas K, Falk RS, Bøhn SKH, Kiserud C, Lie HC, Smedsland SK, Ewertz M, Dahl S, Brekke M, Reinertsen KV (2022)
    Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
    Breast Cancer Res Treat, 193 (3), 685-694
    DOI 10.1007/s10549-022-06599-z, PubMed 35445949
  178. Vandraas KF, Reinertsen KV, Kiserud CE, Bøhn SK, Lie HC (2022)
    Health literacy among long-term survivors of breast cancer; exploring associated factors in a nationwide sample
    Support Care Cancer, 30 (9), 7587-7596
    DOI 10.1007/s00520-022-07183-3, PubMed 35674792
  179. Weider T, Genoni A, Broccolo F, Paulsen TH, Dahl-Jørgensen K, Toniolo A, Hammerstad SS (2022)
    High Prevalence of Common Human Viruses in Thyroid Tissue
    Front Endocrinol (Lausanne), 13, 938633
    DOI 10.3389/fendo.2022.938633, PubMed 35909527
  180. Westerveld H, Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Spampinato S, Sturdza A, Nesvacil N, Bruheim K, Hellebust TP, Pieters BR, Kirisits C, Jürgenliemk-Schulz IM, Pötter R, de Leeuw AAC (2022)
    Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
    Radiother Oncol, 168, 8-15
    DOI 10.1016/j.radonc.2021.12.034, PubMed 35063582
  181. Winther RR, Hjermstad MJ, Skovlund E, Aass N, Helseth E, Kaasa S, Yri OE, Vik-Mo EO (2022)
    Surgery for brain metastases-impact of the extent of resection
    Acta Neurochir (Wien), 164 (10), 2773-2780
    DOI 10.1007/s00701-021-05104-7, PubMed 35080651
  182. Wolf J, Helland Å, Oh IJ, Migliorino MR, Dziadziuszko R, Wrona A, de Castro J, Mazieres J, Griesinger F, Chlistalla M, Cardona A, Ruf T, Trunzer K, Smoljanovic V, Novello S (2022)
    Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
    ESMO Open, 7 (1), 100333
    DOI 10.1016/j.esmoop.2021.100333, PubMed 35042152
  183. Yri OE, Aass N, Kaasa S (2022)
    [Whole brain radiotherapy should be restricted]
    Tidsskr Nor Laegeforen, 142 (17)
    DOI 10.4045/tidsskr.22.0696, PubMed 36416654
  184. Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
    Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
    ESMO Open, 7 (5), 100588
    DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420
  185. Aass N, Kaasa S (2022)
    Patient-centred care - is it possible?
    Tidsskr Nor Laegeforen, 142 (3)
    DOI 10.4045/tidsskr.22.0072, PubMed 35170916

Publications 2021

  1. Abrahamsen CS, Lang-Ree HM, Halvorsen K, Stenbakken CM (2021)
    Patients with COPD: Exploring patients' coping ability during an interdisciplinary pulmonary rehabilitation programme: A qualitative focus group study
    J Clin Nurs, 30 (9-10), 1479-1488
    DOI 10.1111/jocn.15700, PubMed 33555629
  2. Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
    T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
    Nat Biotechnol, 40 (4), 488-498
    DOI 10.1038/s41587-021-01089-x, PubMed 34873326
  3. Aljabri B, Lilleby W, Switlyk MD, Tafjord G (2021)
    Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
    Urol Case Rep, 37, 101648
    DOI 10.1016/j.eucr.2021.101648, PubMed 33868933
  4. Alonso-Álvarez S, Manni M, Montoto S, Sarkozy C, Morschhauser F, Wondergem MJ, Guarini A, Magnano L, Alcoceba M, Chamuleau M, Galimberti S, Gomes da Silva M, Holte H, Zucca E, Lockmer S, Aurer I, Marcheselli L, Stepanishyna Y, Caballero Barrigón MD, Salles G, Federico M (2021)
    Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
    Eur J Cancer, 157, 132-139
    DOI 10.1016/j.ejca.2021.08.005, PubMed 34508995
  5. Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K (2021)
    Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
    Qual Life Res, 30 (12), 3367-3381
    DOI 10.1007/s11136-021-02908-z, PubMed 34146226
  6. ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB (2021)
    Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
    Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
    DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970
  7. Areklett EW, Fagereng E, Bruheim K, Andersson S, Lindemann K (2021)
    Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study
    Psychooncology, 31 (2), 298-305
    DOI 10.1002/pon.5818, PubMed 34516040
  8. Autio M, Leivonen SK, Brück O, Mustjoki S, Mészáros Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppä S (2021)
    Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
    Haematologica, 106 (3), 718-729
    DOI 10.3324/haematol.2019.243626, PubMed 32079690
  9. Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2021)
    One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison
    Eur J Surg Oncol, 47 (7), 1651-1660
    DOI 10.1016/j.ejso.2021.01.011, PubMed 33518367
  10. Balstad TR, Brunelli C, Pettersen CH, Schønberg SA, Skorpen F, Fallon M, Kaasa S, Bye A, Laird BJA, Stene GB, Solheim TS (2021)
    Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
    Front Nutr, 7, 602775
    DOI 10.3389/fnut.2020.602775, PubMed 33585533
  11. Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
    Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
    Cancers (Basel), 13 (7)
    DOI 10.3390/cancers13071565, PubMed 33805367
  12. Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L (2021)
    Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
    Mol Oncol, 15 (8), 2026-2045
    DOI 10.1002/1878-0261.12951, PubMed 33759347
  13. Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE et al. (2021)
    Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
    Am J Hum Genet, 108 (7), 1190-1203
    DOI 10.1016/j.ajhg.2021.05.013, PubMed 34146516
  14. Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å (2021)
    Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
    Front Oncol, 11, 674731
    DOI 10.3389/fonc.2021.674731, PubMed 34109123
  15. Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U, Culine S, de Wit R, Hansen AR, Bebek M, Terbuch A, Albany C, Hentrich M, Gietema JA, Negaard H, Huddart RA, Lorch A, Cafferty FH, Heng DYC, Sweeney CJ, Winquist E et al. (2021)
    Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
    J Clin Oncol, 39 (14), 1553-1562
    DOI 10.1200/JCO.20.03292, PubMed 33729863
  16. Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn I, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Müller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S et al. (2021)
    Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
    N Engl J Med, 386 (7), 629-639
    DOI 10.1056/NEJMoa2116596, PubMed 34904798
  17. Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
    The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
    Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
    DOI 10.1093/ehjci/jeaa289, PubMed 33152065
  18. Bjaanæs MM, Nilsen G, Halvorsen AR, Russnes HG, Solberg S, Jørgensen L, Brustugun OT, Lingjærde OC, Helland Å (2021)
    Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
    BMC Cancer, 21 (1), 1089
    DOI 10.1186/s12885-021-08811-7, PubMed 34625038
  19. Bjaanæs MM, Sande EPS, Loe Ø, Ramberg C, Næss TM, Ottestad A, Rogg LV, Svestad JG, Haakensen VD (2021)
    Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer
    Phys Imaging Radiat Oncol, 18, 51-54
    DOI 10.1016/j.phro.2021.04.003, PubMed 34258408
  20. Blakkisrud J, Løndalen A, Dahle J, Martinsen AC, Kolstad A, Stokke C (2021)
    Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
    Acta Oncol, 60 (11), 1481-1488
    DOI 10.1080/0284186X.2021.1959635, PubMed 34425735
  21. Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
    The use of reTURB in T1 bladder cancer: a Norwegian population-based study
    Scand J Urol, 55 (4), 268-274
    DOI 10.1080/21681805.2021.1917652, PubMed 33998957
  22. Bong WK, Gaustadnes LM, Bergland A, Chen W, Bye A (2021)
    Community-living older people's interpretation of the Norwegian version of older people's quality of life (OPQOL) questionnaire
    Health Soc Care Community, 29 (6), 1695-1705
    DOI 10.1111/hsc.13273, PubMed 33440057
  23. Bonsaksen T, Ekeberg Ø, Schou-Bredal I, Skogstad L, Heir T, Grimholt TK (2021)
    Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems
    Front Public Health, 9, 667729
    DOI 10.3389/fpubh.2021.667729, PubMed 34195169
  24. Bonsaksen T, Skogstad L, Grimholt TK, Heir T, Ekeberg O, Lerdal A, Schou-Bredal I (2021)
    Substance use in the Norwegian general population: prevalence and associations with disease
    J. Subst. Use, 26 (2), 144-150
    DOI 10.1080/14659891.2020.1784303
  25. Borchgrevink PC, Glette M, Woodhouse A, Butler S, Landmark T, Romundstad P, Dale O, Stiles TC, Bonaa KH, Thorsvik D, Thünte S, Kaasa S (2021)
    A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study)
    J Pain, 23 (2), 337-348
    DOI 10.1016/j.jpain.2021.08.007, PubMed 34551343
  26. Borgen IMH, Kleffelgård I, Hauger SL, Forslund MV, Søberg HL, Andelic N, Sveen U, Winter L, Løvstad M, Røe C (2021)
    Patient-Reported Problem Areas in Chronic Traumatic Brain Injury
    J Head Trauma Rehabil, 37 (5), E336-E345
    DOI 10.1097/HTR.0000000000000744, PubMed 34743086
  27. Borza T, Harneshaug M, Kirkhus L, Šaltytė Benth J, Selbæk G, Bergh S, Slaaen M (2021)
    The course of depressive symptoms and mortality in older patients with cancer
    Aging Ment Health, 26 (6), 1153-1160
    DOI 10.1080/13607863.2021.1932739, PubMed 34139140
  28. Bousquet PA, Meltzer S, Fuglestad AJ, Lüders T, Esbensen Y, Juul HV, Johansen C, Lyckander LG, Bjørnetrø T, Inderberg EM, Kersten C, Redalen KR, Ree AH (2021)
    The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression
    Clin Transl Oncol, 24 (6), 1157-1167
    DOI 10.1007/s12094-021-02756-w, PubMed 34961902
  29. Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
    Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
    Cancer Immunol Immunother, 70 (9), 2617-2624
    DOI 10.1007/s00262-021-02876-w, PubMed 33580363
  30. Brenne AT, Løhre ET, Knudsen AK, Thronæs M, Lund JÅ, Kongshaug N, Neverdal MN, Rystad K, Johansen MH, Braseth TI, Kaasa S (2021)
    Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway
    Oncol Ther, 9 (2), 671-693
    DOI 10.1007/s40487-021-00176-y, PubMed 34731447
  31. Brustugun OT (2021)
    Cancer and coronavirus risk
    Tidsskr Nor Laegeforen, 141 (2)
    DOI 10.4045/tidsskr.20.1044, PubMed 33528129
  32. Brustugun OT, Heggelund L (2021)
    [COVID-19 vaccination of cancer patients]
    Tidsskr Nor Laegeforen, 141 (3)
    DOI 10.4045/tidsskr.21.0026, PubMed 33624982
  33. Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
    E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
    Mol Oncol, 16 (12), 2312-2329
    DOI 10.1002/1878-0261.13159, PubMed 34890102
  34. Bugge C, Kaasa S, Sæther EM, Melberg HO, Sonbo Kristiansen I (2021)
    What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
    BMJ Open, 11 (9), e050564
    DOI 10.1136/bmjopen-2021-050564, PubMed 34580099
  35. Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
    Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
    TH Open, 5 (1), e14-e23
    DOI 10.1055/s-0040-1721782, PubMed 33564742
  36. Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
    Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 33 (1), 20-33
    DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
  37. Caulier B, Enserink JM, Wälchli S (2021)
    Pharmacologic Control of CAR T Cells
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094320, PubMed 33919245
  38. Chen X, Badian RA, Hynne H, Amdal CD, Herlofson BB, Utheim ØA, Westgaard KL, Fineide F, Jensen JL, Utheim TP (2021)
    Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
    Sci Rep, 11 (1), 22419
    DOI 10.1038/s41598-021-01844-9, PubMed 34789830
  39. Choudhury A, Theophanous S, Lønne PI, Samuel R, Guren MG, Berbee M, Brown P, Lilley J, van Soest J, Dekker A, Gilbert A, Malinen E, Wee L, Appelt AL (2021)
    Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study
    Radiother Oncol, 159, 183-189
    DOI 10.1016/j.radonc.2021.03.013, PubMed 33753156
  40. Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2021)
    Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
    Leukemia, 36 (1), 177-188
    DOI 10.1038/s41375-021-01311-4, PubMed 34244612
  41. Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2021)
    A Controlled Study of Major Depressive Episodes in Long-Term Childhood, Adolescence, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
    Cancers (Basel), 13 (22)
    DOI 10.3390/cancers13225800, PubMed 34830953
  42. Damhuis RAM, Senan S, Khakwani A, Harden S, Helland Ȧ, Strand TE (2021)
    Age-related treatment patterns for stage I NSCLC in three European countries
    J Geriatr Oncol, 12 (8), 1214-1219
    DOI 10.1016/j.jgo.2021.05.005, PubMed 33994330
  43. Dillard P, Casey N, Pollmann S, Vernhoff P, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2021)
    Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
    Oncoimmunology, 10 (1), 1936757
    DOI 10.1080/2162402X.2021.1936757, PubMed 34235003
  44. Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
    Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
    Transpl Int, 34 (11), 2205-2213
    DOI 10.1111/tri.13995, PubMed 34792825
  45. Eide IJZ, Brustugun OT (2021)
    [Lung cancer treated abroad with receptor tyrosine kinase inhibitor]
    Tidsskr Nor Laegeforen, 141
    DOI 10.4045/tidsskr.21.0147, PubMed 34505490
  46. Eide IJZ, Grut H, Helland Å, Ekman S, Sørensen JB, Hansen KH, Grønberg BH, Cicenas S, Koivunen JP, Mellemgaard A, Brustugun OT (2021)
    Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
    Acta Oncol, 60 (12), 1565-1571
    DOI 10.1080/0284186X.2021.1973092, PubMed 34486915
  47. Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2021)
    Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life
    Acta Oncol, 60 (7), 911-920
    DOI 10.1080/0284186X.2021.1917776, PubMed 33905285
  48. Engebraaten O, Yau C, Berg K, Borgen E, Garred Ø, Berstad MEB, Fremstedal ASV, DeMichele A, Veer LV', Esserman L, Weyergang A (2021)
    RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
    Nat Commun, 12 (1), 6427
    DOI 10.1038/s41467-021-26018-z, PubMed 34741021
  49. Eriksen GF, Šaltytė Benth J, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Hjelstuen A, Slaaen M (2021)
    Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study
    Acta Oncol, 61 (4), 393-402
    DOI 10.1080/0284186X.2021.2009561, PubMed 34874228
  50. Eriksson M, Reichardt P, Joensuu H, Krarup-Hansen A, Hagberg O, Hohenberger P, Hagberg H, Hansson L, Foukakis T, Pulkkanen K, Bauer S, Goplen D, Blach Rossen P, Sundby Hall K (2021)
    Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
    ESMO Open, 6 (4), 100217
    DOI 10.1016/j.esmoop.2021.100217, PubMed 34271307
  51. Fankhauser CD, Oldenburg J, Albers P, Algaba F, Bokemeyer C, Boormans JL, Fischer S, Fizazi K, Gremmels H, Mayor de Castro J, Janisch F, Muilwijk T, Leão R, Nicol D, Nicolai N, Tandstad T, Pilar Laguna M (2021)
    Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
    Eur Urol, 80 (1), 4-6
    DOI 10.1016/j.eururo.2021.02.032, PubMed 33722419
  52. Farooqi SJ, Bjaanæs MM, Helland Å, Haakensen VD (2021)
    [Immunotherapy for malignant pleural mesothelioma]
    Tidsskr Nor Laegeforen, 141
    DOI 10.4045/tidsskr.21.0503, PubMed 34505475
  53. Farooqi SJ, Helland A, Haakensen VD, Bjaanaes MM (2021)
    Immunotherapy in malignant pleural mesothelioma
    Tidsskr. Nor. Laegeforen., 141 (12), 1167-1169
  54. Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
    Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
    Cancers (Basel), 13 (16)
    DOI 10.3390/cancers13164076, PubMed 34439229
  55. Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM (2021)
    Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
    J Immunother Cancer, 9 (10)
    DOI 10.1136/jitc-2021-003109, PubMed 34711663
  56. Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2021)
    Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
    Nat Med, 28 (2), 325-332
    DOI 10.1038/s41591-021-01622-0, PubMed 34921238
  57. Frafjord A, Buer L, Hammarström C, Aamodt H, Woldbæk PR, Brustugun OT, Helland Å, Øynebråten I, Corthay A (2021)
    The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
    Front Immunol, 12, 764596
    DOI 10.3389/fimmu.2021.764596, PubMed 34868011
  58. Fåne A, Myhre MR, Inderberg EM, Wälchli S (2021)
    In vivo experimental mouse model to test CD19CAR T cells generated with different methods
    Methods Cell Biol, 167, 149-161
    DOI 10.1016/bs.mcb.2021.11.001, PubMed 35152992
  59. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
    Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
    Pathology, 53 (6), 713-719
    DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
  60. Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
    Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
    Eur Urol Oncol, 5 (2), 235-243
    DOI 10.1016/j.euo.2021.02.002, PubMed 33750683
  61. Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A et al. (2021)
    Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
    J Clin Oncol, 39 (14), 1563-1574
    DOI 10.1200/JCO.20.03296, PubMed 33822655
  62. Gjersvik P, Heikkila R, Johansen TEB (2021)
    Rescue treatment for cancer
    Tidsskr. Nor. Laegeforen., 141 (5), 487
  63. Groendahl AR, Moe YM, Kaushal CK, Huynh BN, Rusten E, Tomic O, Hernes E, Hanekamp B, Undseth C, Guren MG, Malinen E, Futsaether CM (2021)
    Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI
    Acta Oncol, 61 (1), 89-96
    DOI 10.1080/0284186X.2021.1994645, PubMed 34783610
  64. Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
    A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
    Phys Med Biol, 66 (6), 065012
    DOI 10.1088/1361-6560/abe553, PubMed 33666176
  65. Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A et al. (2021)
    Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 32 (11), 1348-1365
    DOI 10.1016/j.annonc.2021.07.006, PubMed 34303806
  66. Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO (2021)
    High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
    Lancet Oncol, 22 (3), 321-331
    DOI 10.1016/S1470-2045(20)30742-7, PubMed 33662285
  67. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
    Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
    NPJ Digit Med, 4 (1), 33
    DOI 10.1038/s41746-021-00398-4, PubMed 33619361
  68. Guldvik IJ, Ekseth L, Kishan AU, Stensvold A, Inderberg EM, Lilleby W (2021)
    Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
    J Pers Med, 11 (7)
    DOI 10.3390/jpm11070605, PubMed 34206815
  69. Gullhaug A, Hjermstad MJ, Yri O, Svestad JG, Aass N, Johansen S (2021)
    Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study
    J Med Imaging Radiat Sci, 52 (2), 214-222
    DOI 10.1016/j.jmir.2021.01.002, PubMed 33549504
  70. Guren MG, Sebag-Montefiore D, Franco P, Johnsson A, Segelov E, Deutsch E, Rao S, Spindler KG, Arnold D (2021)
    Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer
    Clin Colorectal Cancer, 20 (4), 279-287
    DOI 10.1016/j.clcc.2021.09.006, PubMed 34645589
  71. Habberstad R, Frøseth TCS, Aass N, Bjerkeset E, Abramova T, Garcia-Alonso E, Caputo M, Rossi R, Boland JW, Brunelli C, Lund JÅ, Kaasa S, Klepstad P (2021)
    Clinical Predictors for Analgesic Response to Radiotherapy in Patients with Painful Bone Metastases
    J Pain Symptom Manage, 62 (4), 681-690
    DOI 10.1016/j.jpainsymman.2021.03.022, PubMed 33794301
  72. Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjaerde OC, Tveit KM, Pallisgaard N, Spindler KG, Kure EH (2021)
    Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
    Int J Cancer, 149 (6), 1385-1397
    DOI 10.1002/ijc.33672, PubMed 33961700
  73. Hamfjord J, Myklebust TÅ, Larsen IK, Kure EH, Glimelius B, Guren TK, Tveit KM, Guren MG (2021)
    Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
    Cancer Epidemiol Biomarkers Prev, 31 (2), 342-351
    DOI 10.1158/1055-9965.EPI-21-0555, PubMed 34853022
  74. Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Rydén L, Fehm T, Aft R, Solà M, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching PA, Fernö M, Krawczyk N, Weilbaecher K, Margelí M, Hahn M et al. (2021)
    Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
    Eur J Cancer, 154, 128-137
    DOI 10.1016/j.ejca.2021.06.028, PubMed 34265505
  75. Haugen MH, Lingjærde OC, Hedenfalk I, Garred Ø, Borgen E, Loman N, Hatschek T, Børresen-Dale AL, Naume B, Mills GB, Mælandsmo GM, Engebraaten O (2021)
    Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
    JCO Precis Oncol, 5
    DOI 10.1200/PO.20.00086, PubMed 34036235
  76. Haugnes HS, Negaard HF, Jensvoll H, Wilsgaard T, Tandstad T, Solberg A (2021)
    Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study
    Eur Urol Open Sci, 32, 19-27
    DOI 10.1016/j.euros.2021.07.007, PubMed 34667955
  77. Heck A, Winge-Main AK (2021)
    Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
    BMJ Case Rep, 14 (5)
    DOI 10.1136/bcr-2021-241981, PubMed 34045201
  78. Heikkilä R, Myklebust TÅ, Møller B (2021)
    Regional variation in cancer survival in Norway
    Cancer Epidemiol, 75, 102038
    DOI 10.1016/j.canep.2021.102038, PubMed 34571393
  79. Hellesnes R, Myklebust TÅ, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS (2021)
    Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
    J Clin Oncol, 39 (32), 3561-3573
    DOI 10.1200/JCO.21.00637, PubMed 34388002
  80. Hermansen JU, Wojcik DM, Robinson N, Pahnke J, Haugland HK, Jamtøy AH, Flaegstad T, Halvorsen H, Lund B, Baumbusch LO, Munthe-Kaas MC (2021)
    The Norwegian childhood cancer biobank
    Cancer Rep (Hoboken), 5 (8), e1555
    DOI 10.1002/cnr2.1555, PubMed 34541832
  81. Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
    Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
    PET Clin, 16 (2), 147-165
    DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
  82. Hernæs KH, Smeland KB, Fagerli UM, Kiserud CE (2021)
    Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
    BMC Cancer, 21 (1), 143
    DOI 10.1186/s12885-021-07836-2, PubMed 33557789
  83. Hjermstad MJ, Hamfjord J, Aass N, Dajani O, Lundeby T, Wester T, Kaasa S (2021)
    Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway-Results from a Cluster Randomized Trial
    Cancers (Basel), 13 (9)
    DOI 10.3390/cancers13092194, PubMed 34063594
  84. Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ (2021)
    A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
    JCI Insight, 6 (16)
    DOI 10.1172/jci.insight.149217, PubMed 34423789
  85. Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
    Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
    Eur J Cancer, 151, 150-158
    DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
  86. Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
    Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
    Scand J Urol, 55 (4), 287-292
    DOI 10.1080/21681805.2021.1946135, PubMed 34196594
  87. Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
    Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
    Cancers (Basel), 13 (3)
    DOI 10.3390/cancers13030485, PubMed 33513877
  88. Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
    Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
    Am J Ophthalmol Case Rep, 22, 101106
    DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
  89. Høghaug G, Skår R, Tran TN, Diep LM, Bredal IS (2021)
    Three-month follow-up effects of a medication management program on nurses' knowledge
    Nurse Educ Pract, 51, 102979
    DOI 10.1016/j.nepr.2021.102979, PubMed 33588183
  90. Hølmebakk T, Boye K (2021)
    ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann Surg Oncol, 28 (11), 6846-6847
    DOI 10.1245/s10434-021-09608-5, PubMed 33687615
  91. Hølmebakk T, Boye K (2021)
    Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
    Ann Surg Oncol, 28 (Suppl 3), 873
    DOI 10.1245/s10434-021-09939-3, PubMed 33829360
  92. Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
    Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
    Ann Surg Oncol, 28 (11), 6837-6845
    DOI 10.1245/s10434-021-09605-8, PubMed 33651216
  93. Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å (2021)
    NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
    J Transl Med, 19 (1), 232
    DOI 10.1186/s12967-021-02905-3, PubMed 34059094
  94. Isaksen KT, Mastroianni MA, Rinde M, Rusten LS, Barzenje DA, Ramslien LF, Slaaen M, Jerm MB, Smeland EB, Rostoft S, Liestøl K, Brodtkorb M, Holte H (2021)
    A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
    Blood Adv, 5 (22), 4771-4782
    DOI 10.1182/bloodadvances.2021004777, PubMed 34543384
  95. Ito J, Minemura T, Wälchli S, Niimi T, Fujihara Y, Kuroda S, Takimoto K, Maturana AD (2021)
    Id2 Represses Aldosterone-Stimulated Cardiac T-Type Calcium Channels Expression
    Int J Mol Sci, 22 (7)
    DOI 10.3390/ijms22073561, PubMed 33808082
  96. Jakobsen J, Veierød MB, Grimsrud TK, Fosså SD, Hammarström B, Kjærheim K (2021)
    Early detection of prostate cancer in firefighters: a register-based study of prognostic factors and survival
    Occup Environ Med, 79 (3), 200-206
    DOI 10.1136/oemed-2021-107622, PubMed 34510005
  97. Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å (2021)
    COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
    Front Oncol, 11, 652535
    DOI 10.3389/fonc.2021.652535, PubMed 33842366
  98. Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021)
    In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study
    Breast Cancer Res, 23 (1), 17
    DOI 10.1186/s13058-021-01393-z, PubMed 33526044
  99. Johnson ML, Zvirbule Z, Laktionov K, Helland A, Cho BC, Gutierrez V, Colinet B, Lena H, Wolf M, Gottfried M, Okamoto I, van der Leest C, Rich P, Hung JY, Appenzeller C, Sun Z, Maag D, Luo Y, Nickner C, Vajikova A, Komarnitsky P, Bar J (2021)
    Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
    J Thorac Oncol, 16 (9), 1570-1581
    DOI 10.1016/j.jtho.2021.03.012, PubMed 33823285
  100. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
  101. Karlsson AT, Hjermstad MJ, Omdahl T, Aass N, Skovlund E, Hellebust TP, Johansen S, Kaasa S, Yri OE (2021)
    Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer
    Acta Oncol, 60 (8), 1054-1060
    DOI 10.1080/0284186X.2021.1924399, PubMed 34032536
  102. Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F (2021)
    Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
    Cancers (Basel), 13 (22)
    DOI 10.3390/cancers13225848, PubMed 34831000
  103. Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
    Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
    Acta Vet Scand, 63 (1), 41
    DOI 10.1186/s13028-021-00608-9, PubMed 34732227
  104. Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Sundset M, van Limbergen E, Villafranca E, Westerveld H, Tan LT, Pötter R, Tanderup K, Nout RA et al. (2021)
    Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
    Int J Radiat Oncol Biol Phys, 112 (2), 400-413
    DOI 10.1016/j.ijrobp.2021.08.036, PubMed 34478833
  105. Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S et al. (2021)
    Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
    JAMA Netw Open, 4 (7), e2115312
    DOI 10.1001/jamanetworkopen.2021.15312, PubMed 34196715
  106. Knuth F, Adde IA, Huynh BN, Groendahl AR, Winter RM, Negård A, Holmedal SH, Meltzer S, Ree AH, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Futsaether CM (2021)
    MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts
    Acta Oncol, 61 (2), 255-263
    DOI 10.1080/0284186X.2021.2013530, PubMed 34918621
  107. Korwisi B, Hay G, Attal N, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Giamberardino MA, Kaasa S, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Treede RD, Rief W, Barke A (2021)
    Classification algorithm for the International Classification of Diseases-11 chronic pain classification: development and results from a preliminary pilot evaluation
    Pain, 162 (7), 2087-2096
    DOI 10.1097/j.pain.0000000000002208, PubMed 33492033
  108. Kryeziu K, Moosavi SH, Bergsland CH, Guren MG, Eide PW, Totland MZ, Lassen K, Abildgaard A, Nesbakken A, Sveen A, Lothe RA (2021)
    Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
    J Transl Med, 19 (1), 384
    DOI 10.1186/s12967-021-03062-3, PubMed 34496878
  109. Krüger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, Garred Ø, Naume B, Engebraaten O, Akslen LA (2021)
    Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
    Sci Rep, 11 (1), 3388
    DOI 10.1038/s41598-021-81914-0, PubMed 33564016
  110. Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F et al. (2021)
    Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
    Pediatr Blood Cancer, 68 (4), e28903
    DOI 10.1002/pbc.28903, PubMed 33538093
  111. Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD (2021)
    Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score
    Transpl Int, 34 (9), 1722-1732
    DOI 10.1111/tri.13981, PubMed 34448271
  112. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
    Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
    JAMA Oncol, 7 (1), e205865
    DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
  113. Larsen BH, Lundeby T, Gerwing J, Gulbrandsen P, Førde R (2021)
    "Eh - What type of cells are these - flourishing in the liver?" Cancer patients' disclosure of existential concerns in routine hospital consultations
    Patient Educ Couns, 105 (7), 2019-2026
    DOI 10.1016/j.pec.2021.11.010, PubMed 34839995
  114. Larsen SG, Goscinski MA, Dueland S, Steigen SE, Hofsli E, Torgunrud A, Lund-Iversen M, Dagenborg VJ, Flatmark K, Sorbye H (2021)
    Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
    Br J Cancer, 126 (5), 726-735
    DOI 10.1038/s41416-021-01620-6, PubMed 34887523
  115. Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, Umer HM, Mermelekas G, Pirmoradian M, Jönsson M, Brunnström H, Brustugun OT, Purohit KP, Cunningham R, Foroughi Asl H, Isaksson S, Arbajian E, Aine M, Karlsson A, Kotevska M, Gram Hansen C, Drageset Haakensen V, Helland Å, Tamborero D, Johansson HJ et al. (2021)
    Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
    Nat Cancer, 2 (11), 1224-1242
    DOI 10.1038/s43018-021-00259-9, PubMed 34870237
  116. Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
    Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
    Curr Radiopharm, 14 (2), 145-153
    DOI 10.2174/1874471013666201201102056, PubMed 33261548
  117. Lien TG, Ohnstad HO, Lingjærde OC, Vallon-Christersson J, Aaserud M, Sveli MAT, Borg Å, Osbreac OBO, Garred Ø, Borgen E, Naume B, Russnes H, Sørlie T (2021)
    Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
    Cancers (Basel), 13 (23)
    DOI 10.3390/cancers13236118, PubMed 34885228
  118. Lilleheie I, Debesay J, Bye A, Bergland A (2021)
    The tension between carrying a burden and feeling like a burden: a qualitative study of informal caregivers' and care recipients' experiences after patient discharge from hospital
    Int J Qual Stud Health Well-being, 16 (1), 1855751
    DOI 10.1080/17482631.2020.1855751, PubMed 33345749
  119. Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R (2021)
    The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
    J Thorac Oncol, 16 (7), 1200-1210
    DOI 10.1016/j.jtho.2021.03.019, PubMed 33823286
  120. Lindberg Å, Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbaek K, Geisler CH, Jerkeman M (2021)
    Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience
    Hematol Oncol, 40 (1), 22-30
    DOI 10.1002/hon.2940, PubMed 34713465
  121. Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
    Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Cancers (Basel), 13 (6)
    DOI 10.3390/cancers13061367, PubMed 33803531
  122. Liposits G, Orrevall Y, Kaasa S, Osterlund P, Cederholm T (2021)
    Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice
    JCO Oncol. Pract., 17 (7), 442-+
    DOI 10.1200/OP.20.00704
  123. Lokhande L, Kuci Emruli V, Eskelund CW, Kolstad A, Hutchings M, Räty R, Niemann CU, Grønbaek K, Jerkeman M, Ek S (2021)
    Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
    Cancer Rep (Hoboken), 5 (7), e1524
    DOI 10.1002/cnr2.1524, PubMed 34319003
  124. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2021)
    Choroid Plexus Tumors in Children: Long-Term Follow-Up of Consecutive Single-Institutional Series of 59 Patients Treated over a Period of 8 Decades (1939-2020)
    World Neurosurg, 158, e810-e819
    DOI 10.1016/j.wneu.2021.11.070, PubMed 34823041
  125. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
    World Neurosurg, 150, e228-e235
    DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
  126. Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
    Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
    Br J Neurosurg, 38 (2), 514-522
    DOI 10.1080/02688697.2021.1914821, PubMed 34096810
  127. Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Chen W, Dajani O, Mariussen KL, Steindal SA (2021)
    Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-Based Palliative Care: Protocol for a Scoping Review
    JMIR Res Protoc, 10 (10), e33305
    DOI 10.2196/33305, PubMed 34714254
  128. Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
    Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
    Int J Behav Nutr Phys Act, 18 (1), 62
    DOI 10.1186/s12966-021-01123-w, PubMed 33971901
  129. Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
    Correction to: Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
    Int J Behav Nutr Phys Act, 18 (1), 80
    DOI 10.1186/s12966-021-01152-5, PubMed 34172048
  130. Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment
    Eur J Surg Oncol, 47 (9), 2377-2383
    DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
  131. Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F et al. (2021)
    Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
    Lancet Oncol, 23 (1), 125-137
    DOI 10.1016/S1470-2045(21)00470-8, PubMed 34895479
  132. Meltzer S, Torgunrud A, Abrahamsson H, Solbakken AM, Flatmark K, Dueland S, Bakke KM, Bousquet PA, Negård A, Johansen C, Lyckander LG, Larsen FO, Schou JV, Redalen KR, Ree AH (2021)
    The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
    Br J Cancer, 125 (2), 240-246
    DOI 10.1038/s41416-021-01377-y, PubMed 33837301
  133. Mensali N, Dillard P, Fayzullin A, Köksal H, Gaudernack G, Kvalheim G, Inderberg EM, Wälchli S (2021)
    "Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms
    FASEB J, 35 (9), e21750
    DOI 10.1096/fj.202100025R, PubMed 34424568
  134. Merrien M, Wasik AM, Ljung E, Morsy MHA, de Matos Rodrigues J, Carlsten M, Rassidakis GZ, Christensson B, Kolstad A, Jerkeman M, Ek S, Herold N, Wahlin BE, Sander B (2021)
    Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
    Virchows Arch, 480 (3), 655-666
    DOI 10.1007/s00428-021-03228-w, PubMed 34738194
  135. Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
    Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
    Eur J Nucl Med Mol Imaging, 48 (9), 2782-2792
    DOI 10.1007/s00259-020-05125-x, PubMed 33559711
  136. Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, Røsok BI, Brudvik KW, Bjørnbeth BA, Guren MG, Nesbakken A, Lothe RA, Sveen A (2021)
    De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
    Genome Med, 13 (1), 143
    DOI 10.1186/s13073-021-00956-1, PubMed 34470666
  137. Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J et al. (2021)
    Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
    Breast Cancer Res, 23 (1), 86
    DOI 10.1186/s13058-021-01450-7, PubMed 34407845
  138. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
    Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
    Clin Transl Radiat Oncol, 28, 39-47
    DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
  139. Murray C, von Possel N, Lie HC, Breivik J (2021)
    The Nine Cancer Frames: A Tool to Facilitate Critical Reading of Cancer-Related Information
    J Cancer Educ, 37 (6), 1918-1927
    DOI 10.1007/s13187-021-02062-7, PubMed 34279845
  140. Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O (2021)
    Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
    Sci Rep, 11 (1), 15582
    DOI 10.1038/s41598-021-94812-2, PubMed 34341387
  141. Nakken S, Lilleby W, Switlyk MD, Knudsen KE, Lilleby O, Zhao S, Kaveh F, Ekstrøm PO, Urbanucci A, Hovig E (2021)
    The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
    J Pers Med, 11 (5)
    DOI 10.3390/jpm11050330, PubMed 33922147
  142. Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
    Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
    PLoS One, 16 (3), e0248133
    DOI 10.1371/journal.pone.0248133, PubMed 33662039
  143. Nilssen Y, Eriksen MT, Guren MG, Møller B (2021)
    Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
    BMC Cancer, 21 (1), 757
    DOI 10.1186/s12885-021-08415-1, PubMed 34187404
  144. Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang J, Johnson J, Russnes HG, Bravo-Cordero JJ, Birbrair A, Naume B, Azhar M, Frenette PS, Aguirre-Ghiso JA (2021)
    Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGFβ2
    Nat Cancer, 2 (3), 327-339
    DOI 10.1038/s43018-021-00179-8, PubMed 34993493
  145. Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
    Thyroid hypofunction in aging testicular cancer survivors
    Acta Oncol, 60 (11), 1452-1458
    DOI 10.1080/0284186X.2021.1958004, PubMed 34351829
  146. Olsen CF, Bergland A, Bye A, Debesay J, Langaas AG (2021)
    Crossing knowledge boundaries: health care providers' perceptions and experiences of what is important to achieve more person-centered patient pathways for older people
    BMC Health Serv Res, 21 (1), 310
    DOI 10.1186/s12913-021-06312-8, PubMed 33827714
  147. Olsen CF, Bergland A, Debesay J, Bye A, Langaas AG (2021)
    Patient Flow or the Patient's Journey? Exploring Health Care Providers' Experiences and Understandings of Implementing a Care Pathway to Improve the Quality of Transitional Care for Older People
    Qual Health Res, 31 (9), 1710-1723
    DOI 10.1177/10497323211003861, PubMed 34010082
  148. Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2021)
    A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
    Eur Geriatr Med, 12 (6), 1201-1212
    DOI 10.1007/s41999-021-00520-5, PubMed 34086194
  149. Olsen SU, Hesseberg K, Aas AM, Ranhoff AH, Bye A (2021)
    Refeeding syndrome occurs among older adults regardless of refeeding rates: A systematic review
    Nutr Res, 91, 1-12
    DOI 10.1016/j.nutres.2021.05.004, PubMed 34130206
  150. Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M, Dalla Pria A, Danilov A, David KA, Diefenbach C, Ellin F, Epperla N, Farooq U, Feldman TA, Gerrie AS, Jagadeesh D, Kamdar M, Karmali R, Kassam S, Kenkre VP, Khan N, Kim SH, Klein AK et al. (2021)
    Burkitt Lymphoma International Prognostic Index
    J Clin Oncol, 39 (10), 1129-1138
    DOI 10.1200/JCO.20.03288, PubMed 33502927
  151. Osterman E, Ekström J, Sjöblom T, Kørner H, Myklebust TÅ, Guren MG, Glimelius B (2021)
    Accurate population-based model for individual prediction of colon cancer recurrence
    Acta Oncol, 60 (10), 1241-1249
    DOI 10.1080/0284186X.2021.1953138, PubMed 34279175
  152. Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM (2021)
    Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
    Nanomaterials (Basel), 11 (5)
    DOI 10.3390/nano11051140, PubMed 33924869
  153. Paria BC, Levin N, Lowery FJ, Pasetto A, Deniger DC, Parkhurst MR, Yossef R, Kim SP, Florentin M, Ngo LT, Ray S, Krishna S, Robbins PF, Rosenberg SA (2021)
    Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells
    J Immunother, 44 (1), 1-8
    DOI 10.1097/CJI.0000000000000342, PubMed 33086340
  154. Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, Dennis J, Michailidou K, Shah M, Conroy DM, Harrington PA, Mayes R, Czene K, Hall P, Teras LR, Patel AV et al. (2021)
    Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
    Cancers (Basel), 13 (10)
    DOI 10.3390/cancers13102370, PubMed 34069208
  155. Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Borrego MR, Moore HC, Saunders C, Cardoso F et al. (2021)
    Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
    Breast, 59, 327-338
    DOI 10.1016/j.breast.2021.07.021, PubMed 34390999
  156. Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
    Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Nat Commun, 12 (1), 3230
    DOI 10.1038/s41467-021-23445-w, PubMed 34050156
  157. Peters M, de Leeuw AAC, Nomden CN, Tanderup K, Kirchheiner K, Lindegaard JC, Kirisits C, Haie-Meder C, Sturdza A, Fokdal L, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Tan LT, van Rossum PSN, Nesvacil N, Nout R, Schmid MP et al. (2021)
    Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
    Radiother Oncol, 163, 150-158
    DOI 10.1016/j.radonc.2021.08.020, PubMed 34480958
  158. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR et al. (2021)
    Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
    Eur Urol, 80 (2), 142-146
    DOI 10.1016/j.eururo.2021.04.035, PubMed 33985797
  159. Pierson SK, Shenoy S, Oromendia AB, Gorzewski AM, Langan Pai RA, Nabel CS, Ruth JR, Parente SAT, Arenas DJ, Guilfoyle M, Reddy M, Weinblatt M, Shadick N, Bower M, Pria AD, Masaki Y, Katz L, Mezey J, Beineke P, Lee D, Tendler C, Kambayashi T, Fosså A, van Rhee F, Fajgenbaum DC (2021)
    Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
    Blood Adv, 5 (17), 3445-3456
    DOI 10.1182/bloodadvances.2020004016, PubMed 34438448
  160. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Guren MG, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Thomsen LA, Moller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I (2021)
    Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. (vol 148, 1575, 2021)
    Int. J. Cancer, 149 (6), E9
    DOI 10.1002/ijc.33717
  161. Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U (2021)
    Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
    J Neuroendocrinol, 33 (5), e12967
    DOI 10.1111/jne.12967, PubMed 33769624
  162. Popat S, Brustugun OT, Cadranel J, Felip E, Garassino MC, Griesinger F, Helland Å, Hochmair M, Pérol M, Bent-Ennakhil N, Kruhl C, Novello S (2021)
    Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer
    Lung Cancer, 157, 9-16
    DOI 10.1016/j.lungcan.2021.05.017, PubMed 34051652
  163. Popperud TH, Gul KA, Brunborg C, Olaussen RW, Abrahamsen TG, Osnes LT, Kerty E (2021)
    Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects
    Front Neurol, 12, 596859
    DOI 10.3389/fneur.2021.596859, PubMed 33716918
  164. Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C et al. (2021)
    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
    Lancet Oncol, 22 (4), 538-547
    DOI 10.1016/S1470-2045(20)30753-1, PubMed 33794207
  165. Ragnum HB, De Bortoli AM, Elsais A, Nilsen KB, Hammarstrom C, Nyakas M (2021)
    A man in his sixties with dyspnoea following immunotherapy
    Tidsskr. Nor. Laegeforen., 141 (12), 1190-1194
  166. Ragnum HB, De Bortoli AM, Elsais A, Nilsen KB, Hammarström C, Nyakas M (2021)
    A man in his sixties with dyspnoea following immunotherapy
    Tidsskr Nor Laegeforen, 141 (2021-12)
    DOI 10.4045/tidsskr.21.0139, PubMed 34505469
  167. Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE, Deutsch E, Martinelli E, Arnold D, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2021)
    Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 32 (9), 1087-1100
    DOI 10.1016/j.annonc.2021.06.015, PubMed 34175386
  168. REACCT Collaborative, Zaborowski AM, Abdile A, Adamina M, Aigner F, d'Allens L, Allmer C, Álvarez A, Anula R, Andric M, Atallah S, Bach S, Bala M, Barussaud M, Bausys A, Bebington B, Beggs A, Bellolio F, Bennett MR, Berdinskikh A, Bevan V, Biondo S, Bislenghi G, Bludau M, Boutall A et al. (2021)
    Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review
    JAMA Surg, 156 (9), 865-874
    DOI 10.1001/jamasurg.2021.2380, PubMed 34190968
  169. Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
    Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
    Acta Radiol, 63 (8), 995-1004
    DOI 10.1177/02841851211027389, PubMed 34171968
  170. Riis ML (2021)
    Management of patients with BRCA mutation from the point of view of a breast surgeon
    Ann Med Surg (Lond), 65, 102311
    DOI 10.1016/j.amsu.2021.102311, PubMed 33996049
  171. Robbrecht D, Jungels C, Sorensen MM, Spanggaard I, Eskens F, Fretland SØ, Guren TK, Aftimos P, Liberg D, Svedman C, Thorsson L, Steeghs N, Awada A (2021)
    First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
    Br J Cancer, 126 (7), 1010-1017
    DOI 10.1038/s41416-021-01657-7, PubMed 34903842
  172. Rodrigues JM, Nikkarinen A, Hollander P, Weibull CE, Räty R, Kolstad A, Amini RM, Porwit A, Jerkeman M, Ek S, Glimelius I (2021)
    Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
    Br J Haematol, 193 (3), 520-531
    DOI 10.1111/bjh.17366, PubMed 33686666
  173. Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, Garred Ø, Riis ML, Osbreac, Lingjaerde OC, Myklebust JH, Russnes HG (2021)
    Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
    Mol Oncol, 16 (1), 88-103
    DOI 10.1002/1878-0261.13047, PubMed 34165864
  174. Røen I, Brenne AT, Brunelli C, Stifoss-Hanssen H, Grande G, Solheim TS, Kaasa S, Knudsen AK (2021)
    Spiritual quality of life in family carers of patients with advanced cancer-a cross-sectional study
    Support Care Cancer, 29 (9), 5329-5339
    DOI 10.1007/s00520-021-06080-5, PubMed 33661369
  175. Rønde HS, Kallehauge JF, Kronborg CJS, Nyvang L, Rekstad BL, Hanekamp BA, Appelt AL, Guren MG, Spindler KLS (2021)
    Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation
    Acta Oncol, 60 (11), 1436-1439
    DOI 10.1080/0284186X.2021.1953139, PubMed 34264785
  176. Schou-Bredal I, Grimholt T, Bonsaksen T, Skogstad L, Heir T, Ekeberg Ø (2021)
    Optimists' and pessimists' self-reported mental and global health during the COVID-19 pandemic in Norway
    Health Psychol Rep, 9 (2), 160-168
    DOI 10.5114/hpr.2021.102394, PubMed 38084286
  177. Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M et al. (2021)
    Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
    Lancet Oncol, 22 (10), 1403-1415
    DOI 10.1016/S1470-2045(21)00375-2, PubMed 34516954
  178. Seierstad T, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Revheim ME, Hernes E (2021)
    18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
    PET Clin, 16 (2), 167-176
    DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662
  179. Seland M, Skrede K, Lindemann K, Skaali T, Blomhoff R, Bruheim K, Wisløff T, Thorsen L (2021)
    Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer
    Acta Obstet Gynecol Scand, 101 (3), 313-322
    DOI 10.1111/aogs.14310, PubMed 34964982
  180. Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, Caputo M, Kaasa S, Caraceni A (2021)
    Neuropathic pain: clinical classification and assessment in patients with pain due to cancer
    Pain, 162 (3), 866-874
    DOI 10.1097/j.pain.0000000000002076, PubMed 32947548
  181. Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Bjordal K, Herlofson BB, Santos M, Silva JC, Mehanna H, Fullerton A, Brannan C, Gonzalez LF, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A et al. (2021)
    Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
    Qual Life Res, 31 (3), 841-853
    DOI 10.1007/s11136-021-02939-6, PubMed 34272632
  182. Skaga E, Skretteberg MA, Johannesen TB, Brandal P, Vik-Mo EO, Helseth E, Langmoen IA (2021)
    Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
    Neurooncol Adv, 3 (1), vdab008
    DOI 10.1093/noajnl/vdab008, PubMed 33665615
  183. Skalleberg J, Myhrum M, Småstuen MC, Osnes TA, Fosså SD, Bunne M (2021)
    Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
    Acta Oncol, 60 (4), 426-433
    DOI 10.1080/0284186X.2021.1887514, PubMed 33617403
  184. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
  185. Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
    Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
    Acta Oncol, 60 (7), 921-930
    DOI 10.1080/0284186X.2021.1918763, PubMed 33966592
  186. Smet S, Spampinato S, Pötter R, Jürgenliemk-Schulz IM, Nout RA, Chargari C, Mahantshetty U, Sturdza A, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, Van der Steen-Banasik E, Sundset M, Van Limbergen E, Tan LT, Lutgens LCHW, Villafranca E, Pieters BR, Tanderup K, Kirchheiner K (2021)
    Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
    Int J Radiat Oncol Biol Phys, 112 (5), 1177-1189
    DOI 10.1016/j.ijrobp.2021.11.022, PubMed 34838868
  187. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
    Radiother Oncol, 158, 312-320
    DOI 10.1016/j.radonc.2021.01.019, PubMed 33545254
  188. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Response to Yuce Sari et al
    Radiother Oncol, 158, 323-324
    DOI 10.1016/j.radonc.2021.02.022, PubMed 33647355
  189. Spampinato S, Jensen NBK, Pötter R, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Lutgens LCHW, Tan LT, Villafranca E, Smet S, Jastaniyah N et al. (2021)
    Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
    Int J Radiat Oncol Biol Phys, 112 (3), 681-693
    DOI 10.1016/j.ijrobp.2021.09.055, PubMed 34678431
  190. Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S (2021)
    [Cancer therapy with isolated limb perfusion]
    Tidsskr Nor Laegeforen, 141 (2021-12)
    DOI 10.4045/tidsskr.21.0194, PubMed 34505491
  191. Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø (2021)
    Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
    Clin Cancer Res, 27 (10), 2755-2763
    DOI 10.1158/1078-0432.CCR-20-3435, PubMed 33542073
  192. Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A et al. (2021)
    Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
    Cancer, 127 (16), 2934-2942
    DOI 10.1002/cncr.33618, PubMed 33910263
  193. Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A et al. (2021)
    Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
    ESMO Open, 6 (3), 100170
    DOI 10.1016/j.esmoop.2021.100170, PubMed 34090171
  194. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
  195. Stikbakke E, Schirmer H, Knutsen T, Støyten M, Wilsgaard T, Giovannucci EL, McTiernan A, Eggen AE, Haugnes HS, Richardsen E, Thune I (2021)
    Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
    Cancer Med, 11 (4), 1005-1015
    DOI 10.1002/cam4.4523, PubMed 34939344
  196. Stjernberg M, Schlichting E, Rustoen T, Valeberg BT, Småstuen MC, Raeder JC (2021)
    Postdischarge pain, nausea and patient satisfaction after diagnostic and breast-conserving ambulatory surgery for breast cancer: A cross-sectional study
    Acta Anaesthesiol Scand, 66 (3), 317-325
    DOI 10.1111/aas.14015, PubMed 34888855
  197. Storås AH, Fosså SD, Ursin G, Andreassen BK (2021)
    Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
    Prostate Cancer Prostatic Dis, 26 (1), 53-58
    DOI 10.1038/s41391-021-00445-x, PubMed 34493838
  198. Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, de Álava E, Dei Tos AP, Garcia Del Muro X, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A et al. (2021)
    Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
    Ann Oncol, 32 (12), 1520-1536
    DOI 10.1016/j.annonc.2021.08.1995, PubMed 34500044
  199. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
  200. Tabernero J, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Elez E, Gollerkeri A, Maharry K, Christy-Bittel J, Kopetz S (2021)
    Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
    J Clin Oncol, 39 (4), 273-284
    DOI 10.1200/JCO.20.02088, PubMed 33503393
  201. Thorgersen EB, Asvall J, Frøysnes IS, Schjalm C, Larsen SG, Dueland S, Andersson Y, Fodstad Ø, Mollnes TE, Flatmark K (2021)
    Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Ann Surg Oncol, 28 (9), 5252-5262
    DOI 10.1245/s10434-021-10022-0, PubMed 34019185
  202. Thorsen L, Bøhn SH, Lie HC, Fosså SD, Kiserud CE (2021)
    Needs for information about lifestyle and rehabilitation in long-term young adult cancer survivors
    Support Care Cancer, 30 (1), 521-533
    DOI 10.1007/s00520-021-06418-z, PubMed 34333716
  203. Thorsteinsdottir T, Brustugun OT (2021)
    [Cholangiocarcinoma treated with a tumour-agnostic drug]
    Tidsskr Nor Laegeforen, 141
    DOI 10.4045/tidsskr.21.0064, PubMed 34505477
  204. Torstveit AH, Løyland B, Grov EK, Guren M, Paul SM, Ritchie C, Vistad I, Miaskowski C, Utne I (2021)
    Distinctions Between Self-Report and Performance-Based Measures of Physical Function in Older Patients Prior to Chemotherapy
    Cancer Nurs, 44 (6), E735-E744
    DOI 10.1097/NCC.0000000000000964, PubMed 34183518
  205. Torstveit AH, Miaskowski C, Løyland B, Grov EK, Guren MG, Ritchie CS, Paul SM, Kleven AG, Utne I (2021)
    Common and distinct characteristics associated with self-reported functional status in older patients with cancer receiving chemotherapy
    Eur J Oncol Nurs, 54, 102033
    DOI 10.1016/j.ejon.2021.102033, PubMed 34537538
  206. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
  207. Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, Brennhovd B, Inderberg EM, Hønnåshagen TK, Skoge LJ, Solum G, Saebøe-Larssen S, Josefsen D, Olaussen RW, Aamdal S, Skotheim RI, Myklebust TÅ, Schendel DJ, Lilleby W, Dueland S, Kvalheim G (2021)
    Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
    Prostate, 82 (2), 245-253
    DOI 10.1002/pros.24267, PubMed 34762317
  208. Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S (2021)
    Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
    Haematologica, 106 (9), 2502-2506
    DOI 10.3324/haematol.2020.278182, PubMed 33764002
  209. Vajavaara H, Mortensen JB, Leivonen SK, Hansen IM, Ludvigsen M, Holte H, Jørgensen J, Bjerre M, d'Amore F, Leppä S (2021)
    Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
    Cancers (Basel), 13 (3)
    DOI 10.3390/cancers13030398, PubMed 33499013
  210. Valsø Å, Rustøen T, Småstuen MC, Puntillo K, Skogstad L, Schou-Bredal I, Sunde K, Tøien K (2021)
    Occurrence and characteristics of pain after ICU discharge: A longitudinal study
    Nurs Crit Care, 27 (5), 718-727
    DOI 10.1111/nicc.12701, PubMed 34382725
  211. van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, van der Kooi ALF, Kremer LCM, Kruseova J, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Spix C, Twisk JWR, Ronckers CM, Kaatsch P, van Dulmen-den Broeder E et al. (2021)
    Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
    Hum Reprod, 36 (6), 1561-1573
    DOI 10.1093/humrep/deab035, PubMed 33744927
  212. van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U et al. (2021)
    Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
    Hum Reprod, 36 (4), 1120-1133
    DOI 10.1093/humrep/deaa342, PubMed 33582778
  213. van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Muraca M, Kaiser M et al. (2021)
    Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
    Cancers (Basel), 13 (18)
    DOI 10.3390/cancers13184598, PubMed 34572825
  214. van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L, Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O (2021)
    Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
    J Clin Med, 10 (22)
    DOI 10.3390/jcm10225334, PubMed 34830615
  215. Venizelos A, Elvebakken H, Perren A, Nikolaienko O, Deng W, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Krogh M, Sorbye H, Knappskog S (2021)
    The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
    Endocr Relat Cancer, 29 (1), 1-14
    DOI 10.1530/ERC-21-0152, PubMed 34647903
  216. Vestre K, Persiconi I, Borg Distefano M, Mensali N, Guadagno NA, Bretou M, Wälchli S, Arnold-Schrauf C, Bakke O, Dalod M, Lennon-Dumenil AM, Progida C (2021)
    Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton
    J Cell Sci, 134 (18)
    DOI 10.1242/jcs.259221, PubMed 34494097
  217. Våde L, Hompland I, Fauske L (2021)
    Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
    Sarcoma, 2021, 2042785
    DOI 10.1155/2021/2042785, PubMed 34421328
  218. Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2021)
    HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
    J Clin Endocrinol Metab, 106 (4), e1763-e1774
    DOI 10.1210/clinem/dgaa958, PubMed 33367784
  219. Westgaard KL, Hynne H, Amdal CD, Young A, Singh PB, Chen X, Rykke M, Hove LH, Aqrawi LA, Utheim TP, Herlofson BB, Jensen JL (2021)
    Oral and ocular late effects in head and neck cancer patients treated with radiotherapy
    Sci Rep, 11 (1), 4026
    DOI 10.1038/s41598-021-83635-w, PubMed 33597629
  220. Winther RR, Vik-Mo EO, Yri OE, Aass N, Kaasa S, Skovlund E, Helseth E, Hjermstad MJ (2021)
    Surgery for brain metastases - real-world prognostic factors' association with survival
    Acta Oncol, 60 (9), 1161-1168
    DOI 10.1080/0284186X.2021.1930150, PubMed 34032547
  221. Wright P, Arnesen MR, Lønne PI, Suilamo S, Silvoniemi A, Dale E, Minn H, Malinen E (2021)
    Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer
    Acta Oncol, 60 (11), 1386-1391
    DOI 10.1080/0284186X.2021.1944663, PubMed 34184605
  222. Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H et al. (2021)
    Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
    JAMA Netw Open, 4 (12), e2138550
    DOI 10.1001/jamanetworkopen.2021.38550, PubMed 34902034
  223. Yap TA, Nakagawa K, Fujimoto N, Kuribayashi K, Guren TK, Calabrò L, Shapira-Frommer R, Gao B, Kao S, Matos I, Planchard D, Chatterjee A, Jin F, Norwood K, Kindler HL (2021)
    Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
    Lancet Respir Med, 9 (6), 613-621
    DOI 10.1016/S2213-2600(20)30515-4, PubMed 33836153
  224. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
    MRI pulse sequence integration for deep-learning-based brain metastases segmentation
    Med Phys, 48 (10), 6020-6035
    DOI 10.1002/mp.15136, PubMed 34405896
  225. Öjlert ÅK, Nebdal D, Snapkov I, Olsen V, Kidman J, Greiff V, Chee J, Helland Å (2021)
    Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
    Mol Oncol, 15 (11), 2958-2968
    DOI 10.1002/1878-0261.13082, PubMed 34402187
  226. Aamdal E, Inderberg EM, Ellingsen EB, Rasch W, Brunsvig PF, Aamdal S, Heintz KM, Vodák D, Nakken S, Hovig E, Nyakas M, Guren TK, Gaudernack G (2021)
    Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
    Front Immunol, 12, 663865
    DOI 10.3389/fimmu.2021.663865, PubMed 34046035
  227. Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
    Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
    Int J Cancer, 150 (1), 100-111
    DOI 10.1002/ijc.33768, PubMed 34449877
  228. Aas K, Berge V, Myklebust TÅ, Fosså SD (2021)
    Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
    Eur Urol Open Sci, 26, 55-63
    DOI 10.1016/j.euros.2021.01.011, PubMed 34337508

Publications 2020

  1. Abravan A, Eide HA, Helland Å, Malinen E (2020)
    Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
    Clin Transl Radiat Oncol, 22, 15-21
    DOI 10.1016/j.ctro.2020.02.005, PubMed 32181373
  2. Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2020)
    In Reply to Sari et al
    Int J Radiat Oncol Biol Phys, 107 (2), 388-389
    DOI 10.1016/j.ijrobp.2020.02.027, PubMed 32112877
  3. Al-Haidari G, Skovlund E, Undseth C, Rekstad BL, Larsen SG, Åsli LM, Dueland S, Malinen E, Guren MG (2020)
    Re-irradiation for recurrent rectal cancer - a single-center experience
    Acta Oncol, 59 (5), 534-540
    DOI 10.1080/0284186X.2020.1725111, PubMed 32056476
  4. Aqrawi LA, Chen X, Hynne H, Amdal C, Reppe S, Aass HCD, Rykke M, Hove LH, Young A, Herlofson BB, Westgaard KL, Utheim TP, Galtung HK, Jensen JL (2020)
    Cytokines Explored in Saliva and Tears from Radiated Cancer Patients Correlate with Clinical Manifestations, Influencing Important Immunoregulatory Cellular Pathways
    Cells, 9 (9)
    DOI 10.3390/cells9092050, PubMed 32911805
  5. Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, Ferlay J, Tervonen H, Shack L, Woods RR, Saint-Jacques N, De P, McClure C, Engholm G, Gavin AT, Morgan E, Walsh PM, Jackson C, Porter G, Møller B, Bucher O, Eden M, O'Connell DL, Bray F, Soerjomataram I (2020)
    Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)
    Gut, 70 (1), 114-126
    DOI 10.1136/gutjnl-2020-320625, PubMed 32482683
  6. Ascierto PA, Del Vecchio M, Mackiewicz A, Robert C, Chiarion-Sileni V, Arance A, Lebbé C, Svane IM, McNeil C, Rutkowski P, Loquai C, Mortier L, Hamid O, Bastholt L, Dreno B, Schadendorf D, Garbe C, Nyakas M, Grob JJ, Thomas L, Liszkay G, Smylie M, Hoeller C, Ferraresi V, Grange F et al. (2020)
    Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma
    J Immunother Cancer, 8 (1)
    DOI 10.1136/jitc-2019-000391, PubMed 32503946
  7. Ask EH, Tschan-Plessl A, Gjerdingen TJ, Sætersmoen ML, Hoel HJ, Wiiger MT, Olweus J, Wahlin BE, Lingjærde OC, Horowitz A, Cashen AF, Watkins M, Fehniger TA, Holte H, Kolstad A, Malmberg KJ (2020)
    A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma
    Med, 2 (2), 180-195.e5
    DOI 10.1016/j.medj.2020.10.006, PubMed 35590201
  8. Astrup GL, Hofsø K, Bjordal K, Rustøen T (2020)
    Cancer patients' diagnosis and symptoms and their family caregivers' self-efficacy and social support are associated with different caregiver reactions
    Eur J Cancer Care (Engl), 29 (6), e13311
    DOI 10.1111/ecc.13311, PubMed 32885524
  9. Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP, RAPIDO collaborative investigators (2020)
    Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Lancet Oncol, 22 (1), 29-42
    DOI 10.1016/S1470-2045(20)30555-6, PubMed 33301740
  10. Bai B, Myklebust JH, Wälchli S (2020)
    Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology
    Methods Mol Biol, 2115, 445-454
    DOI 10.1007/978-1-0716-0290-4_25, PubMed 32006416
  11. Beisland E, Hauge EM, Aarstad AKH, Hjermstad MJ, Aarstad HJ, Beisland C (2020)
    Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery
    Scand J Urol, 54 (4), 304-312
    DOI 10.1080/21681805.2020.1773528, PubMed 32500779
  12. Bell L, Holloway L, Bruheim K, Petrič P, Kirisits C, Tanderup K, Pötter R, Vinod S, Lim K, Pogson E, Metcalfe P, Hellebust TP (2020)
    Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
    Brachytherapy, 19 (2), 146-153
    DOI 10.1016/j.brachy.2020.01.002, PubMed 32067884
  13. Benard E, Casey NP, Inderberg EM, Wälchli S (2020)
    SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy
    Scand J Immunol, 92 (4), e12917
    DOI 10.1111/sji.12917, PubMed 32557659
  14. Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
    Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
    ESMO Open, 5 (6), e001040
    DOI 10.1136/esmoopen-2020-001040, PubMed 33219056
  15. Bersvendsen HS, Haugnes HS, Dahl AA, Fagerli UM, Fluge Ø, Holte H, Wilsgaard T, Smeland KB, Kiserud CE (2020)
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
    Bone Marrow Transplant, 56 (4), 968-970
    DOI 10.1038/s41409-020-01098-5, PubMed 33139869
  16. Bhave P, Pallan L, Long GV, Menzies AM, Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M, Kahler K, Hauschild A, Plummer R, Trojaniello C, Ascierto PA, Zimmer L, Schadendorf D, Allayous C, Lebbe C, Maurichi A, Santinami M, Roy S, Robert C, Lesimple T, Patel S, Versluis JM et al. (2020)
    Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
    Br J Cancer, 124 (3), 574-580
    DOI 10.1038/s41416-020-01121-y, PubMed 33087895
  17. Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, EORTC Quality of Life Group and Breast Cancer Group (2020)
    Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288
    Ann Oncol, 31 (4), 552
    DOI 10.1016/j.annonc.2020.02.001, PubMed 32089397
  18. Bjerkeset E, Röhrl K, Schou-Bredal I (2020)
    Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
    Breast Cancer Res Treat, 180 (1), 63-71
    DOI 10.1007/s10549-020-05522-8, PubMed 31938939
  19. Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
    T1 bladder cancer in Norway: treatment and survival
    Scand J Urol, 54 (5), 370-375
    DOI 10.1080/21681805.2020.1803401, PubMed 32783590
  20. Bonsaksen T, Heir T, Skogstad L, Grimholt TK, Ekeberg O, Lerdal A, Schou-Bredal I (2020)
    Daily use of alcohol in the Norwegian general population: Prevalence and associated factors
    Drugs Alcohol Today, 20 (2), 109-121
    DOI 10.1108/DAT-02-2020-0010
  21. Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Bäckström G, Kerna I, Gubanski M, Björnlinger K, Evensen ME, Kuddu M, Pettersson E, Brydøy M, Hellebust TP, Dale E, Valdman A, Weber L, Høyer M (2020)
    A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
    Acta Oncol, 59 (10), 1157-1163
    DOI 10.1080/0284186X.2020.1817977, PubMed 32902341
  22. Brenne AT, Knudsen AK, Raj SX, Skjelvan L, Lund JÅ, Thronæs M, Løhre ET, Hågensen LÅ, Brunelli C, Kaasa S (2020)
    Fully Integrated Oncology and Palliative Care Services at a Local Hospital in Mid-Norway: Development and Operation of an Innovative Care Delivery Model
    Pain Ther, 9 (1), 297-318
    DOI 10.1007/s40122-020-00163-7, PubMed 32274655
  23. Breugom AJ, Bastiaannet E, Guren MG, Kørner H, Boelens PG, Dekker FW, Kapiteijn E, Gelderblom H, Larsen IK, Liefers GJ, van de Velde CJH (2020)
    Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway
    Eur J Surg Oncol, 46 (6), 1167-1173
    DOI 10.1016/j.ejso.2020.02.005, PubMed 32151531
  24. Brunelli C, Borreani C, Caraceni A, Roli A, Bellazzi M, Lombi L, Zito E, Pellegrini C, Spada P, Kaasa S, Foschi AM, Apolone G, PATIENT VOICES study group (2020)
    PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study
    Health Qual Life Outcomes, 18 (1), 252
    DOI 10.1186/s12955-020-01501-1, PubMed 32723341
  25. Brunsvig PF, Guren TK, Nyakas M, Steinfeldt-Reisse CH, Rasch W, Kyte JA, Juul HV, Aamdal S, Gaudernack G, Inderberg EM (2020)
    Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
    Front Immunol, 11, 572172
    DOI 10.3389/fimmu.2020.572172, PubMed 33324397
  26. Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
    Dietary changes in